,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1378024,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),Ginsenoside rh4 inhibits the reaction [[dietary fats co-treated with streptozocin] results in decreased expression of SOD2 mrna]|[dietary fats co-treated with streptozocin] results in decreased expression of SOD2 mRNA,,,PMID:33359794,https://www.ncbi.nlm.nih.gov/pubmed/33359794,33359794,,
1,1378025,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),Quercetin inhibits the reaction [streptozocin results in decreased expression of SOD2 protein],,,PMID:26887929,https://www.ncbi.nlm.nih.gov/pubmed/26887929,26887929,,
2,1378026,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),SIRT1 protein inhibits the reaction [streptozocin results in decreased expression of sod2]|streptozocin results in decreased expression of SOD2,,,PMID:22744176,https://www.ncbi.nlm.nih.gov/pubmed/22744176,22744176,,
3,1378027,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),SIRT1 protein inhibits the reaction [streptozocin results in decreased expression of SOD2 protein],,,PMID:21778425,https://www.ncbi.nlm.nih.gov/pubmed/21778425,21778425,,
4,1378889,31677,Toxin and Toxin Target Database (T3DB),Butachlor,T3D1087,Butachlor,http://www.t3db.ca/toxins/T3D1087,BE0002433,Cytochrome P450 1A2,http://www.t3db.ca/biodb/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
5,1378890,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0000742,DNA topoisomerase 2-alpha,http://www.t3db.ca/biodb/bio_entities/BE0000742,P11388,DNA topoisomerase 2-alpha,7153.0,TOP2A,9606,Homo sapiens (human),"Doxorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: doxorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.",,,PMID:11752352|PMID:17010609|PMID:17351394|PMID:17016621|PMID:17578914|PMID:17089011|PMID:11430001,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/17010609|https://www.ncbi.nlm.nih.gov/pubmed/17351394|https://www.ncbi.nlm.nih.gov/pubmed/17016621|https://www.ncbi.nlm.nih.gov/pubmed/17578914|https://www.ncbi.nlm.nih.gov/pubmed/17089011|https://www.ncbi.nlm.nih.gov/pubmed/11430001,11752352|17010609|17351394|17016621|17578914|17089011|11430001,,
6,1378891,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0000971,DNA topoisomerase 1,http://www.t3db.ca/biodb/bio_entities/BE0000971,P11387,DNA topoisomerase 1,7150.0,TOP1,9606,Homo sapiens (human),,,,PMID:11430001|PMID:20662543,https://www.ncbi.nlm.nih.gov/pubmed/11430001|https://www.ncbi.nlm.nih.gov/pubmed/20662543,11430001|20662543,,
7,1378892,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0000031,7-dehydrocholesterol reductase,http://www.t3db.ca/biodb/bio_entities/BE0000031,Q9UBM7,7-dehydrocholesterol reductase,1717.0,DHCR7,9606,Homo sapiens (human),,,,PMID:15588086,https://www.ncbi.nlm.nih.gov/pubmed/15588086,15588086,,
8,1378893,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0000642,72 kDa type IV collagenase,http://www.t3db.ca/biodb/bio_entities/BE0000642,P08253,72 kDa type IV collagenase,4313.0,MMP2,9606,Homo sapiens (human),,,,PMID:1322986,https://www.ncbi.nlm.nih.gov/pubmed/1322986,1322986,,
9,1378894,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0000991,Aurora kinase A,http://www.t3db.ca/biodb/bio_entities/BE0000991,O14965,Aurora kinase A,6790.0,AURKA,9606,Homo sapiens (human),,,,PMID:21664013,https://www.ncbi.nlm.nih.gov/pubmed/21664013,21664013,,
10,1378895,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0005805,Fas-binding factor 1,http://www.t3db.ca/biodb/bio_entities/BE0005805,Q8TES7,Fas-binding factor 1,85302.0,FBF1,9606,Homo sapiens (human),,,,PMID:17378599,https://www.ncbi.nlm.nih.gov/pubmed/17378599,17378599,,
11,1378896,31703,Toxin and Toxin Target Database (T3DB),Doxorubicin,T3D2953,Doxorubicin,http://www.t3db.ca/toxins/T3D2953,BE0000785,Multidrug resistance-associated protein 1,http://www.t3db.ca/biodb/bio_entities/BE0000785,P33527,Multidrug resistance-associated protein 1 ,4363.0,ABCC1,9606,Homo sapiens (human),,,,PMID:8621644,https://www.ncbi.nlm.nih.gov/pubmed/8621644,8621644,,
12,1379622,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7114,TMSB4X,https://ctdbase.org/detail.go?type=gene&acc=7114,,,7114.0,TMSB4X,9606,Homo sapiens (human),TMSB4X protein inhibits the reaction [doxorubicin results in increased activity of CASP3 protein]|tmsb4x protein results in decreased susceptibility to doxorubicin|tmsb4x protein inhibits the reaction [doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein],,,PMID:16364925,https://www.ncbi.nlm.nih.gov/pubmed/16364925,16364925,,
13,1379623,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,25840,TMT1A,https://ctdbase.org/detail.go?type=gene&acc=25840,,,25840.0,TMT1A,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TMT1A mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
14,1379624,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,83857,TMTC1,https://ctdbase.org/detail.go?type=gene&acc=83857,,,83857.0,TMTC1,9606,Homo sapiens (human),Doxorubicin affects the expression of TMTC1 mRNA,,,PMID:25529476,https://www.ncbi.nlm.nih.gov/pubmed/25529476,25529476,,
15,1379625,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,83857,TMTC1,https://ctdbase.org/detail.go?type=gene&acc=83857,,,83857.0,TMTC1,9606,Homo sapiens (human),Doxorubicin results in increased expression of TMTC1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
16,1379626,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,160335,TMTC2,https://ctdbase.org/detail.go?type=gene&acc=160335,,,160335.0,TMTC2,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TMTC2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
17,1379627,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,81542,TMX1,https://ctdbase.org/detail.go?type=gene&acc=81542,,,81542.0,TMX1,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TMX1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
18,1380216,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Corilagin inhibits the reaction [doxorubicin results in increased expression of TNF protein],,,PMID:34369273|PMID:34605098,https://www.ncbi.nlm.nih.gov/pubmed/34369273|https://www.ncbi.nlm.nih.gov/pubmed/34605098,34369273|34605098,,
19,1380217,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [doxorubicin results in increased expression of TNF protein],,,PMID:26807765,https://www.ncbi.nlm.nih.gov/pubmed/26807765,26807765,,
20,1380218,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [doxorubicin results in increased expression of TNF protein],,,PMID:29315967,https://www.ncbi.nlm.nih.gov/pubmed/29315967,29315967,,
21,1381187,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased secretion of TNFSF10 protein,,,PMID:15703961,https://www.ncbi.nlm.nih.gov/pubmed/15703961,15703961,,
22,1381188,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8742,TNFSF12,https://ctdbase.org/detail.go?type=gene&acc=8742,,,8742.0,TNFSF12,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of TNFSF12 protein|curcumin inhibits the reaction [doxorubicin results in increased expression of TNFSF12 protein],,,PMID:34047412,https://www.ncbi.nlm.nih.gov/pubmed/34047412,34047412,,
23,1381189,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10673,TNFSF13B,https://ctdbase.org/detail.go?type=gene&acc=10673,,,10673.0,TNFSF13B,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TNFSF13B mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
24,1381190,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8740,TNFSF14,https://ctdbase.org/detail.go?type=gene&acc=8740,,,8740.0,TNFSF14,10116,Rattus norvegicus (Norway rat),[doxorubicin co-treated with fungal polysaccharides] results in decreased expression of TNFSF14 mRNA,,,PMID:27181935,https://www.ncbi.nlm.nih.gov/pubmed/27181935,27181935,,
25,1381191,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,10318,TNIP1,https://ctdbase.org/detail.go?type=gene&acc=10318,,,10318.0,TNIP1,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TNIP1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
26,1381192,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,79155,TNIP2,https://ctdbase.org/detail.go?type=gene&acc=79155,,,79155.0,TNIP2,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TNIP2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
27,1381193,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8658,TNKS,https://ctdbase.org/detail.go?type=gene&acc=8658,,,8658.0,TNKS,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TNKS mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
28,1381194,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7134,TNNC1,https://ctdbase.org/detail.go?type=gene&acc=7134,,,7134.0,TNNC1,9606,Homo sapiens (human),Doxorubicin affects the expression of TNNC1 protein,,,PMID:29385562,https://www.ncbi.nlm.nih.gov/pubmed/29385562,29385562,,
29,1381536,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,51086,TNNI3K,https://ctdbase.org/detail.go?type=gene&acc=51086,,,51086.0,TNNI3K,9606,Homo sapiens (human),Doxorubicin results in decreased expression of TNNI3K mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
30,1380391,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116,Rattus norvegicus (Norway rat),Sodium azide inhibits the reaction [adenosine triphosphate results in increased expression of FOS mrna],,,PMID:10723097,https://www.ncbi.nlm.nih.gov/pubmed/10723097,10723097,,
31,1380392,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,9796,Equus caballus (horse),Sodium azide results in decreased susceptibility to [salsolinol co-treated with [FTH1 protein binds to FTL protein]],,,PMID:19433265,https://www.ncbi.nlm.nih.gov/pubmed/19433265,19433265,,
32,1380393,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,2512,FTL,https://ctdbase.org/detail.go?type=gene&acc=2512,,,2512.0,FTL,9796,Equus caballus (horse),Sodium azide results in decreased susceptibility to [salsolinol co-treated with [FTH1 protein binds to FTL protein]],,,PMID:19433265,https://www.ncbi.nlm.nih.gov/pubmed/19433265,19433265,,
33,1380394,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116,Rattus norvegicus (Norway rat),Sodium azide affects the expression of HIF1A protein,,,PMID:16034640,https://www.ncbi.nlm.nih.gov/pubmed/16034640,16034640,,
34,1380395,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606,Homo sapiens (human),Sodium azide inhibits the reaction [IFNG protein results in increased activity of DUOX2 protein],,,PMID:16970942,https://www.ncbi.nlm.nih.gov/pubmed/16970942,16970942,,
35,1380396,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,176278,IKKE-1,https://ctdbase.org/detail.go?type=gene&acc=176278,,,176278.0,ikke-1,6239,Caenorhabditis elegans,IKKE-1 protein promotes the reaction [sodium azide affects the localization of SKN-1 protein],,,PMID:17964427,https://www.ncbi.nlm.nih.gov/pubmed/17964427,17964427,,
36,1380397,33557,Comparative Toxicogenomics Database (CTD),Sodium azide,D019810,Sodium Azide,https://ctdbase.org/detail.go?type=chem&acc=D019810,3768,KCNJ12,https://ctdbase.org/detail.go?type=gene&acc=3768,,,3768.0,KCNJ12,10090,Mus musculus (house mouse),Sodium azide inhibits the reaction [KCNJ12 protein results in increased transport of potassium],,,PMID:12118013,https://www.ncbi.nlm.nih.gov/pubmed/12118013,12118013,,
37,1378166,54889,ChEMBL,Moexipril Hydrochloride,CHEMBL1200534,MOEXIPRIL HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200534/,CHEMBL1808,Angiotensin-converting enzyme,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1808/,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606,Homo sapiens (human),Angiotensin-converting enzyme inhibitor,,,,,,,
38,1378167,54891,ChEMBL,Quinapril Hydrochloride,CHEMBL1201011,QUINAPRIL HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201011/,CHEMBL1808,Angiotensin-converting enzyme,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1808/,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606,Homo sapiens (human),Angiotensin-converting enzyme inhibitor,,,,,,,
39,1379185,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,17224,MCPT1,https://ctdbase.org/detail.go?type=gene&acc=17224,,,17224.0,Mcpt1,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of MCPT1 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
40,1379186,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,17227,MCPT4,https://ctdbase.org/detail.go?type=gene&acc=17227,,,17227.0,Mcpt4,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of MCPT4 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
41,1379187,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,79772,MCTP1,https://ctdbase.org/detail.go?type=gene&acc=79772,,,79772.0,MCTP1,9606,Homo sapiens (human),Raloxifene hydrochloride results in increased expression of MCTP1 mRNA,,,PMID:19429434,https://www.ncbi.nlm.nih.gov/pubmed/19429434,19429434,,
42,1379188,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,29969,MDFIC,https://ctdbase.org/detail.go?type=gene&acc=29969,,,29969.0,MDFIC,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of MDFIC mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
43,1379189,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,29969,MDFIC,https://ctdbase.org/detail.go?type=gene&acc=29969,,,29969.0,MDFIC,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of MDFIC mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
44,1379190,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with PX-866] results in decreased phosphorylation of MDM2 protein,,,PMID:27017931,https://www.ncbi.nlm.nih.gov/pubmed/27017931,27017931,,
45,1379191,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,4205,MEF2A,https://ctdbase.org/detail.go?type=gene&acc=4205,,,4205.0,MEF2A,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of MEF2A mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
46,1379192,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,8076,MFAP5,https://ctdbase.org/detail.go?type=gene&acc=8076,,,8076.0,MFAP5,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of MFAP5 mrna|esr1 protein affects the reaction [raloxifene hydrochloride results in decreased expression of MFAP5 mrna],,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
47,1379193,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,7955,Danio rerio (zebrafish),Raloxifene hydrochloride affects the expression of MGMT mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
48,1380866,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,100506658,OCLN,https://ctdbase.org/detail.go?type=gene&acc=100506658,,,100506658.0,OCLN,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in increased expression of OCLN mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
49,1380867,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,449859,ODF2B,https://ctdbase.org/detail.go?type=gene&acc=449859,,,449859.0,odf2b,7955,Danio rerio (zebrafish),Raloxifene hydrochloride results in increased expression of ODF2B mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
50,1380868,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,10439,OLFM1,https://ctdbase.org/detail.go?type=gene&acc=10439,,,10439.0,OLFM1,9606,Homo sapiens (human),Raloxifene hydrochloride results in decreased expression of OLFM1 mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
51,1380869,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,169611,OLFML2A,https://ctdbase.org/detail.go?type=gene&acc=169611,,,169611.0,OLFML2A,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of OLFML2A mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
52,1380870,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,258285,OR10AL6,https://ctdbase.org/detail.go?type=gene&acc=258285,,,258285.0,Or10al6,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of OR10AL6 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
53,1380871,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,287000,OR1F45,https://ctdbase.org/detail.go?type=gene&acc=287000,,,287000.0,Or1f45,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of OR1F45 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
54,1380872,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,26031,OSBPL3,https://ctdbase.org/detail.go?type=gene&acc=26031,,,26031.0,OSBPL3,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR1 protein] results in increased expression of OSBPL3 mrna|[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of OSBPL3 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
55,1380873,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,114881,OSBPL7,https://ctdbase.org/detail.go?type=gene&acc=114881,,,114881.0,OSBPL7,9606,Homo sapiens (human),Raloxifene hydrochloride results in increased expression of OSBPL7 mRNA,,,PMID:19429434,https://www.ncbi.nlm.nih.gov/pubmed/19429434,19429434,,
56,1380874,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,78990,OTUB2,https://ctdbase.org/detail.go?type=gene&acc=78990,,,78990.0,OTUB2,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of OTUB2 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
57,1380875,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,78990,OTUB2,https://ctdbase.org/detail.go?type=gene&acc=78990,,,78990.0,OTUB2,10090,Mus musculus (house mouse),Raloxifene hydrochloride results in decreased expression of OTUB2 mRNA,,,PMID:33269387,https://www.ncbi.nlm.nih.gov/pubmed/33269387,33269387,,
58,1378168,54960,Comparative Toxicogenomics Database (CTD),Bensulfuron-methyl,C071475,methyl bensulfuron,https://ctdbase.org/detail.go?type=chem&acc=C071475,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Methyl bensulfuron results in increased activity of NR1I2 protein,,,PMID:22206814,https://www.ncbi.nlm.nih.gov/pubmed/22206814,22206814,,
59,1378169,55191,ChEMBL,Gepirone,CHEMBL284092,GEPIRONE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL284092/,CHEMBL214,Serotonin 1a (5-HT1a) receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL214/,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606,Homo sapiens (human),Serotonin 1a (5-ht1a) receptor agonist,,,PMID:31347611,https://www.ncbi.nlm.nih.gov/pubmed/31347611,31347611,,
60,1378170,55245,ChEMBL,Mifepristone,CHEMBL1276308,MIFEPRISTONE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1276308/,CHEMBL208,Progesterone receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL208/,P06401,Progesterone receptor,5241.0,PGR,9606,Homo sapiens (human),Progesterone receptor antagonist,,,,,,,
61,1378171,57030,ChEMBL,Brequinar,CHEMBL38434,BREQUINAR,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL38434/,CHEMBL1966,Dihydroorotate dehydrogenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1966/,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",1723.0,DHODH,9606,Homo sapiens (human),Dihydroorotate dehydrogenase inhibitor,,,PMID:2822596,https://www.ncbi.nlm.nih.gov/pubmed/2822596,2822596,,
62,1378887,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,91012,CERS5,https://ctdbase.org/detail.go?type=gene&acc=91012,,,91012.0,CERS5,9606,Homo sapiens (human),Cidofovir results in increased expression of CERS5 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
63,1378888,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,79745,CLIP4,https://ctdbase.org/detail.go?type=gene&acc=79745,,,79745.0,CLIP4,9606,Homo sapiens (human),Cidofovir results in decreased expression of CLIP4 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
64,1380209,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,9606,Homo sapiens (human),Cidofovir affects the expression of PHGDH mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
65,1380210,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,9606,Homo sapiens (human),Cidofovir results in increased expression of PHLDA3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
66,1380211,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,55367,PIDD1,https://ctdbase.org/detail.go?type=gene&acc=55367,,,55367.0,PIDD1,9606,Homo sapiens (human),Cidofovir affects the expression of PIDD1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
67,1380212,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,8544,PIR,https://ctdbase.org/detail.go?type=gene&acc=8544,,,8544.0,PIR,9606,Homo sapiens (human),Cidofovir results in increased expression of PIR mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
68,1380213,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,5339,PLEC,https://ctdbase.org/detail.go?type=gene&acc=5339,,,5339.0,PLEC,9606,Homo sapiens (human),Cidofovir results in decreased expression of PLEC mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
69,1380214,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,9606,Homo sapiens (human),Cidofovir results in increased expression of PLK3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
70,1380215,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606,Homo sapiens (human),Cidofovir affects the expression of PMAIP1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
71,1380560,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,27289,RND1,https://ctdbase.org/detail.go?type=gene&acc=27289,,,27289.0,RND1,9606,Homo sapiens (human),Cidofovir results in increased expression of RND1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
72,1380561,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,390,RND3,https://ctdbase.org/detail.go?type=gene&acc=390,,,390.0,RND3,9606,Homo sapiens (human),Cidofovir affects the expression of RND3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
73,1380562,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,55298,RNF121,https://ctdbase.org/detail.go?type=gene&acc=55298,,,55298.0,RNF121,9606,Homo sapiens (human),Cidofovir results in decreased expression of RNF121 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
74,1380563,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,6738,RO60,https://ctdbase.org/detail.go?type=gene&acc=6738,,,6738.0,RO60,9606,Homo sapiens (human),Cidofovir results in decreased expression of RO60 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
75,1380564,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,51065,RPS27L,https://ctdbase.org/detail.go?type=gene&acc=51065,,,51065.0,RPS27L,9606,Homo sapiens (human),Cidofovir results in increased expression of RPS27L mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
76,1380565,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,50484,RRM2B,https://ctdbase.org/detail.go?type=gene&acc=50484,,,50484.0,RRM2B,9606,Homo sapiens (human),Cidofovir results in decreased expression of RRM2B mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
77,1380566,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,26156,RSL1D1,https://ctdbase.org/detail.go?type=gene&acc=26156,,,26156.0,RSL1D1,9606,Homo sapiens (human),Cidofovir affects the expression of RSL1D1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
78,1380567,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,65117,RSRC2,https://ctdbase.org/detail.go?type=gene&acc=65117,,,65117.0,RSRC2,9606,Homo sapiens (human),Cidofovir results in decreased expression of RSRC2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
79,1380568,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,861,RUNX1,https://ctdbase.org/detail.go?type=gene&acc=861,,,861.0,RUNX1,9606,Homo sapiens (human),Cidofovir results in increased expression of RUNX1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
80,1380569,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),Cidofovir results in increased expression of RUNX2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
81,1381186,60613,Comparative Toxicogenomics Database (CTD),Cidofovir,D000077404,Cidofovir,https://ctdbase.org/detail.go?type=chem&acc=D000077404,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Cidofovir results in increased expression of TP53 protein,,,PMID:11697818,https://www.ncbi.nlm.nih.gov/pubmed/11697818,11697818,,
82,1366713,62647,Toxin and Toxin Target Database (T3DB),Vanadium(III) chloride,T3D1631,Vanadium(III) chloride,http://www.t3db.ca/toxins/T3D1631,BE0005251,Receptor-type tyrosine-protein phosphatase R,http://www.t3db.ca/biodb/bio_entities/BE0005251,Q15256,Receptor-type tyrosine-protein phosphatase R,5801.0,PTPRR,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
83,1366632,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,175673,C27F2.9,https://ctdbase.org/detail.go?type=gene&acc=175673,,,175673.0,C27F2.9,6239,Caenorhabditis elegans,Mianserin results in increased expression of C27F2.9 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
84,1470816,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1327,COX4I1,https://ctdbase.org/detail.go?type=gene&acc=1327,,,1327.0,COX4I1,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of COX4I1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
85,1470817,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,554101,COX5AA,https://ctdbase.org/detail.go?type=gene&acc=554101,,,554101.0,cox5aa,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of COX5AA mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
86,1470818,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,415253,COX5BA,https://ctdbase.org/detail.go?type=gene&acc=415253,,,415253.0,cox5ba,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of COX5BA mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
87,1470819,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1337,COX6A1,https://ctdbase.org/detail.go?type=gene&acc=1337,,,1337.0,COX6A1,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of COX6A1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
88,1470820,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1340,COX6B1,https://ctdbase.org/detail.go?type=gene&acc=1340,,,1340.0,COX6B1,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide affects the expression of COX6B1 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
89,1470821,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,125965,COX6B2,https://ctdbase.org/detail.go?type=gene&acc=125965,,,125965.0,COX6B2,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of COX6B2 mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
90,1470822,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,1345,COX6C,https://ctdbase.org/detail.go?type=gene&acc=1345,,,1345.0,COX6C,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of COX6C mRNA,,,PMID:31706782,https://www.ncbi.nlm.nih.gov/pubmed/31706782,31706782,,
91,1378509,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10090,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of LEP protein,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
92,1378510,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,55669,MFN1,https://ctdbase.org/detail.go?type=gene&acc=55669,,,55669.0,MFN1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]|bmal1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of MFN1 protein]],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
93,1378511,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),[epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with catechin analog] inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MPO protein]|gallocatechol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MPO protein],,,PMID:26187476,https://www.ncbi.nlm.nih.gov/pubmed/26187476,26187476,,
94,1378512,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,4535,ND1,https://ctdbase.org/detail.go?type=gene&acc=4535,,,4535.0,ND1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
95,1378513,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719.0,NDUFS1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
96,1378514,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein,,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
97,1378515,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),[epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with catechin analog] inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of NOS2 protein],,,PMID:26187476,https://www.ncbi.nlm.nih.gov/pubmed/26187476,26187476,,
98,1378516,72277,Comparative Toxicogenomics Database (CTD),Epigallocatechin,C057580,gallocatechol,https://ctdbase.org/detail.go?type=chem&acc=C057580,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein,,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
99,1379472,73051,Toxin and Toxin Target Database (T3DB),"(1R,3S,4S,6R,8R,9S,10S,13S,14R,16S)-5,5,9,14-tetramethyltetracyclo[11.2.1.01,10.04,8]hexadecane-3,4,6,9,14,16-hexol",T3D3092,Grayanotoxin III,http://www.t3db.ca/toxins/T3D3092,BE0003635,Sodium channel subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0003635,Q07699,Sodium channel subunit beta-1,6324.0,SCN1B,9606,Homo sapiens (human),"Grayanotoxins bind to specific sodium ion channels in cell membranes. the grayanotoxins prevent inactivation, leaving excitable cells depolarized. (L1251)",,,,,,,
100,1378703,73078,Drug Gene Interaction database (DGIdb),Tetrandrine,,FANCHININ,https://www.dgidb.org/drugs/chembl:CHEMBL176045,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606,Homo sapiens (human),,,,,,,,
101,1378704,73087,Comparative Toxicogenomics Database (CTD),3-Deazaneplanocin,C048460,3-deazaneplanocin,https://ctdbase.org/detail.go?type=chem&acc=C048460,693159,MIR574,https://ctdbase.org/detail.go?type=gene&acc=693159,,,693159.0,MIR574,9606,Homo sapiens (human),3-deazaneplanocin results in decreased expression of MIR574 mRNA,,,PMID:23538750,https://www.ncbi.nlm.nih.gov/pubmed/23538750,23538750,,
102,1378705,73252,BindingDB,Tetrachloro-O-benzoquinone,22776,"3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22776,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606,Homo sapiens (human),,Ki (nM),3200,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
103,1378706,73252,BindingDB,Tetrachloro-O-benzoquinone,22776,"3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22776,2315,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2315,P12337,Liver carboxylesterase 1,100009551.0,CES1,9986,Oryctolagus cuniculus (rabbit),,Ki (nM),1035,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
104,1378707,73252,BindingDB,Tetrachloro-O-benzoquinone,22776,"3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22776,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606,Homo sapiens (human),,Ki (nM),1670,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
105,1378708,73252,BindingDB,Tetrachloro-O-benzoquinone,22776,"3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22776,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606,Homo sapiens (human),,Ki (nM),5440,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
106,1378709,73252,BindingDB,Tetrachloro-O-benzoquinone,22776,"3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22776,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606,Homo sapiens (human),,Ki (nM),875,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
107,1379035,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,10116,Rattus norvegicus (Norway rat),Calpeptin inhibits the reaction [acrylamide results in increased expression of MAP2 protein],,,PMID:30096436,https://www.ncbi.nlm.nih.gov/pubmed/30096436,30096436,,
108,1379036,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,10116,Rattus norvegicus (Norway rat),Calpeptin inhibits the reaction [acrylamide results in increased expression of MAPT protein],,,PMID:30096436,https://www.ncbi.nlm.nih.gov/pubmed/30096436,30096436,,
109,1379037,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,9927,MFN2,https://ctdbase.org/detail.go?type=gene&acc=9927,,,9927.0,MFN2,9606,Homo sapiens (human),Calpeptin inhibits the reaction [CAPN1 protein results in increased degradation of MFN2 protein]|calpeptin inhibits the reaction [excitatory amino acid agonists results in decreased expression of MFN2 protein]|calpeptin inhibits the reaction [excitatory amino acid agonists results in increased degradation of MFN2 protein],,,PMID:25416777,https://www.ncbi.nlm.nih.gov/pubmed/25416777,25416777,,
110,1379038,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,9927,MFN2,https://ctdbase.org/detail.go?type=gene&acc=9927,,,9927.0,MFN2,10090,Mus musculus (house mouse),Calpeptin inhibits the reaction [acetaminophen results in decreased expression of and results in increased cleavage of MFN2 protein],,,PMID:35713544,https://www.ncbi.nlm.nih.gov/pubmed/35713544,35713544,,
111,1379039,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,4747,NEFL,https://ctdbase.org/detail.go?type=gene&acc=4747,,,4747.0,NEFL,10116,Rattus norvegicus (Norway rat),Calpeptin inhibits the reaction [calcium results in increased degradation of NEFL protein],,,PMID:11071371,https://www.ncbi.nlm.nih.gov/pubmed/11071371,11071371,,
112,1379184,73466,Comparative Toxicogenomics Database (CTD),Monotropein,C507582,monotropein,https://ctdbase.org/detail.go?type=chem&acc=C507582,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090,Mus musculus (house mouse),Monotropein inhibits the reaction [lipopolysaccharides affects the localization of NFKB1 protein]|monotropein inhibits the reaction [dextran sulfate affects the localization of NFKB1 protein],,,PMID:23261679,https://www.ncbi.nlm.nih.gov/pubmed/23261679,23261679,,
113,1471109,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TF protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
114,1471110,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TFF1 mRNA",,,PMID:24349450|PMID:31059536|PMID:36190352,https://www.ncbi.nlm.nih.gov/pubmed/24349450|https://www.ncbi.nlm.nih.gov/pubmed/31059536|https://www.ncbi.nlm.nih.gov/pubmed/36190352,24349450|31059536|36190352,,
115,1471111,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606,Homo sapiens (human),"Fulvestrant inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of TFF1 mrna]|areg protein affects the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of TFF1 mrna]",,,PMID:31059536,https://www.ncbi.nlm.nih.gov/pubmed/31059536,31059536,,
116,1471112,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10342,TFG,https://ctdbase.org/detail.go?type=gene&acc=10342,,,10342.0,TFG,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TFG protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
117,1471113,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7037,TFRC,https://ctdbase.org/detail.go?type=gene&acc=7037,,,7037.0,TFRC,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of TFRC protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
118,1471114,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of TGFA mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
119,1471115,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7041,TGFB1I1,https://ctdbase.org/detail.go?type=gene&acc=7041,,,7041.0,TGFB1I1,9606,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to TGFB1I1 protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
120,1471116,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7041,TGFB1I1,https://ctdbase.org/detail.go?type=gene&acc=7041,,,7041.0,TGFB1I1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol inhibits the reaction [ESR1 protein binds to TGFB1I1 protein]",,,PMID:29389661,https://www.ncbi.nlm.nih.gov/pubmed/29389661,29389661,,
121,1378162,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of GSTP1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
122,1378163,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of GSTP1 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
123,1378164,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of GSTP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
124,1378165,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased methylation of GSTP1 promoter|perfluorooctane sulfonic acid results in increased expression of GSTP1 mRNA,,,PMID:20621739,https://www.ncbi.nlm.nih.gov/pubmed/20621739,20621739,,
125,1378517,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,404672,GTF2H5,https://ctdbase.org/detail.go?type=gene&acc=404672,,,404672.0,GTF2H5,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of GTF2H5 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of GTF2H5 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of GTF2H5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
126,1378518,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2969,GTF2I,https://ctdbase.org/detail.go?type=gene&acc=2969,,,2969.0,GTF2I,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of GTF2I mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
127,1379765,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55867,SLC22A11,https://ctdbase.org/detail.go?type=gene&acc=55867,,,55867.0,SLC22A11,9606,Homo sapiens (human),SLC22A11 protein results in increased transport of perfluorooctane sulfonic acid,,,PMID:36436016,https://www.ncbi.nlm.nih.gov/pubmed/36436016,36436016,,
128,1379766,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55356,SLC22A15,https://ctdbase.org/detail.go?type=gene&acc=55356,,,55356.0,SLC22A15,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of SLC22A15 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SLC22A15 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SLC22A15 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
129,1379767,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,85413,SLC22A16,https://ctdbase.org/detail.go?type=gene&acc=85413,,,85413.0,SLC22A16,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SLC22A16 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
130,1379768,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51310,SLC22A17,https://ctdbase.org/detail.go?type=gene&acc=51310,,,51310.0,SLC22A17,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of SLC22A17 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
131,1379769,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5002,SLC22A18,https://ctdbase.org/detail.go?type=gene&acc=5002,,,5002.0,SLC22A18,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SLC22A18 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of SLC22A18 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SLC22A18 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
132,1379770,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,207151,SLC22A19,https://ctdbase.org/detail.go?type=gene&acc=207151,,,207151.0,Slc22a19,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of SLC22A19 mRNA,,,PMID:36864359,https://www.ncbi.nlm.nih.gov/pubmed/36864359,36864359,,
133,1379771,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,63027,SLC22A23,https://ctdbase.org/detail.go?type=gene&acc=63027,,,63027.0,SLC22A23,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of SLC22A23 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of SLC22A23 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
134,1380067,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3068,HDGF,https://ctdbase.org/detail.go?type=gene&acc=3068,,,3068.0,HDGF,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of HDGF mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
135,1380068,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3069,HDLBP,https://ctdbase.org/detail.go?type=gene&acc=3069,,,3069.0,HDLBP,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of HDLBP mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
136,1380069,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55127,HEATR1,https://ctdbase.org/detail.go?type=gene&acc=55127,,,55127.0,HEATR1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of HEATR1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
137,1380712,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,20719,SERPINB6A,https://ctdbase.org/detail.go?type=gene&acc=20719,,,20719.0,Serpinb6a,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SERPINB6A mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SERPINB6A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
138,1380713,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,20719,SERPINB6A,https://ctdbase.org/detail.go?type=gene&acc=20719,,,20719.0,Serpinb6a,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of SERPINB6A protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
139,1380714,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,20708,SERPINB6B,https://ctdbase.org/detail.go?type=gene&acc=20708,,,20708.0,Serpinb6b,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SERPINB6B mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of SERPINB6B mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SERPINB6B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
140,1380715,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of SERPINB9 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
141,1380716,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,20706,SERPINB9B,https://ctdbase.org/detail.go?type=gene&acc=20706,,,20706.0,Serpinb9b,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of SERPINB9B protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
142,1380717,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,462,SERPINC1,https://ctdbase.org/detail.go?type=gene&acc=462,,,462.0,SERPINC1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of SERPINC1 mRNA,,,PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/20936131,20936131,,
143,1381042,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3099,HK2,https://ctdbase.org/detail.go?type=gene&acc=3099,,,3099.0,HK2,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the localization of HK2 protein,,,PMID:28288859,https://www.ncbi.nlm.nih.gov/pubmed/28288859,28288859,,
144,1381043,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3101,HK3,https://ctdbase.org/detail.go?type=gene&acc=3101,,,3101.0,HK3,9913,Bos taurus (cattle),Perfluorooctane sulfonic acid results in decreased methylation of HK3 intron|perfluorooctane sulfonic acid results in decreased expression of HK3 mRNA,,,PMID:34762985,https://www.ncbi.nlm.nih.gov/pubmed/34762985,34762985,,
145,1381044,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80201,HKDC1,https://ctdbase.org/detail.go?type=gene&acc=80201,,,80201.0,HKDC1,9031,Gallus gallus (chicken),Perfluorooctane sulfonic acid results in decreased expression of HKDC1 mRNA,,,PMID:17560707,https://www.ncbi.nlm.nih.gov/pubmed/17560707,17560707,,
146,1381045,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80201,HKDC1,https://ctdbase.org/detail.go?type=gene&acc=80201,,,80201.0,HKDC1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of HKDC1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
147,1381046,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3108,HLA-DMA,https://ctdbase.org/detail.go?type=gene&acc=3108,,,3108.0,HLA-DMA,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of HLA-DMA mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
148,1381391,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of GARS1 mRNA,,,PMID:36864359,https://www.ncbi.nlm.nih.gov/pubmed/36864359,36864359,,
149,1381392,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of GARS1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
150,1381393,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,796318,GAS1A,https://ctdbase.org/detail.go?type=gene&acc=796318,,,796318.0,gas1a,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of GAS1A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
151,1381831,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,20437,SIAH1A,https://ctdbase.org/detail.go?type=gene&acc=20437,,,20437.0,Siah1a,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SIAH1A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
152,1381832,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6478,SIAH2,https://ctdbase.org/detail.go?type=gene&acc=6478,,,6478.0,SIAH2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of SIAH2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
153,1379936,75522,BindingDB,"Benzenesulfonamide, p-((p-(dimethylamino)phenyl)azo)-",33269,CHEMBL277836,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33269,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606,Homo sapiens (human),,Ki (nM),6.6,PMID:19773173|DOI:10.1016/j.bmc.2009.09.003,https://www.ncbi.nlm.nih.gov/pubmed/19773173|https://doi.org/10.1016/j.bmc.2009.09.003,19773173,10.1016/j.bmc.2009.09.003,
154,1379937,75522,BindingDB,"Benzenesulfonamide, p-((p-(dimethylamino)phenyl)azo)-",33269,CHEMBL277836,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33269,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),638,PMID:19773173|DOI:10.1016/j.bmc.2009.09.003,https://www.ncbi.nlm.nih.gov/pubmed/19773173|https://doi.org/10.1016/j.bmc.2009.09.003,19773173,10.1016/j.bmc.2009.09.003,
155,1379938,75522,BindingDB,"Benzenesulfonamide, p-((p-(dimethylamino)phenyl)azo)-",33269,CHEMBL277836,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33269,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),,Ki (nM),621,PMID:19773173|DOI:10.1016/j.bmc.2009.09.003,https://www.ncbi.nlm.nih.gov/pubmed/19773173|https://doi.org/10.1016/j.bmc.2009.09.003,19773173,10.1016/j.bmc.2009.09.003,
156,1379939,75729,Toxin and Toxin Target Database (T3DB),Tutin,T3D3089,Tutin,http://www.t3db.ca/toxins/T3D3089,BE0000433,Glycine receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000433,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606,Homo sapiens (human),Tutin is a potent antagonist of the glycine receptor. (L1250),,,,,,,
157,1379940,75729,Toxin and Toxin Target Database (T3DB),Tutin,T3D3089,Tutin,http://www.t3db.ca/toxins/T3D3089,BE0000745,Glycine receptor subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0000745,P23416,Glycine receptor subunit alpha-2,2742.0,GLRA2,9606,Homo sapiens (human),Tutin is a potent antagonist of the glycine receptor. (L1250),,,,,,,
158,1379941,75729,Toxin and Toxin Target Database (T3DB),Tutin,T3D3089,Tutin,http://www.t3db.ca/toxins/T3D3089,BE0000414,Glycine receptor subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0000414,O75311,Glycine receptor subunit alpha-3,8001.0,GLRA3,9606,Homo sapiens (human),Tutin is a potent antagonist of the glycine receptor. (L1250),,,,,,,
159,1379942,75729,Toxin and Toxin Target Database (T3DB),Tutin,T3D3089,Tutin,http://www.t3db.ca/toxins/T3D3089,BE0000055,Glycine receptor subunit beta,http://www.t3db.ca/biodb/bio_entities/BE0000055,P48167,Glycine receptor subunit beta,2743.0,GLRB,9606,Homo sapiens (human),Tutin is a potent antagonist of the glycine receptor. (L1250),,,,,,,
160,1379943,75817,BindingDB,4'-Bromosalicylanilide,234306,N-(4-bromophenyl)-2-hydroxybenzamide (7),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234306,10043,Epidermal growth factor receptor [645-1186],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10043,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606,Homo sapiens (human),,IC50 (nM),50000,PMID:20583855|DOI:10.3109/14756361003671060,https://www.ncbi.nlm.nih.gov/pubmed/20583855|https://doi.org/10.3109/14756361003671060,20583855,10.3109/14756361003671060,
161,1470823,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,9606,Homo sapiens (human),Rosiglitazone inhibits the reaction [methamphetamine results in increased phosphorylation of MAPT protein],,,PMID:31270305,https://www.ncbi.nlm.nih.gov/pubmed/31270305,31270305,,
162,1470824,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,10090,Mus musculus (house mouse),Rosiglitazone results in decreased phosphorylation of MAPT protein|rosiglitazone inhibits the reaction [methamphetamine results in increased phosphorylation of MAPT protein],,,PMID:29981415,https://www.ncbi.nlm.nih.gov/pubmed/29981415,29981415,,
163,1470825,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,10090,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mrna|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mrna]|egf protein inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mrna],,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
164,1471451,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,11343,MGLL,https://ctdbase.org/detail.go?type=gene&acc=11343,,,11343.0,MGLL,10090,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGLL mrna|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGLL mrna],,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
165,1473027,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Rosiglitazone results in decreased activity of CASP3 protein,,,PMID:17255338,https://www.ncbi.nlm.nih.gov/pubmed/17255338,17255338,,
166,1473028,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Rosiglitazone results in decreased expression of CASP3 mRNA,,,PMID:17639046,https://www.ncbi.nlm.nih.gov/pubmed/17639046,17639046,,
167,1473029,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Rosiglitazone results in increased activity of CASP3 protein,,,PMID:17506947|PMID:19467017|PMID:19731824,https://www.ncbi.nlm.nih.gov/pubmed/17506947|https://www.ncbi.nlm.nih.gov/pubmed/19467017|https://www.ncbi.nlm.nih.gov/pubmed/19731824,17506947|19467017|19731824,,
168,1377853,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5265,SERPINA1,https://ctdbase.org/detail.go?type=gene&acc=5265,,,5265.0,SERPINA1,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of SERPINA1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
169,1377854,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,20716,SERPINA3N,https://ctdbase.org/detail.go?type=gene&acc=20716,,,20716.0,Serpina3n,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of SERPINA3N mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
170,1377855,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3053,SERPIND1,https://ctdbase.org/detail.go?type=gene&acc=3053,,,3053.0,SERPIND1,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of SERPIND1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
171,1377856,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of SERPINH1 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
172,1377857,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,6421,SFPQ,https://ctdbase.org/detail.go?type=gene&acc=6421,,,6421.0,SFPQ,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of SFPQ mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
173,1377858,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,6469,SHH,https://ctdbase.org/detail.go?type=gene&acc=6469,,,6469.0,SHH,9606,Homo sapiens (human),Bexarotene results in increased expression of SHH mRNA,,,PMID:26096596,https://www.ncbi.nlm.nih.gov/pubmed/26096596,26096596,,
174,1377859,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,6478,SIAH2,https://ctdbase.org/detail.go?type=gene&acc=6478,,,6478.0,SIAH2,9606,Homo sapiens (human),Bexarotene results in decreased expression of SIAH2 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
175,1377860,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,6507,SLC1A3,https://ctdbase.org/detail.go?type=gene&acc=6507,,,6507.0,SLC1A3,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of SLC1A3 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
176,1377861,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497.0,SLC27A1,10090,Mus musculus (house mouse),Bexarotene results in increased expression of SLC27A1 mrna|[[dexamethasone co-treated with INS protein co-treated with 1-methyl-3-isobutylxanthine] co-treated with bexarotene] results in increased expression of SLC27A1 mRNA,,,PMID:10777552,https://www.ncbi.nlm.nih.gov/pubmed/10777552,10777552,,
177,1378326,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),[dihydro-beta-erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in decreased susceptibility to nicotine,,,PMID:10945867|PMID:16915382,https://www.ncbi.nlm.nih.gov/pubmed/10945867|https://www.ncbi.nlm.nih.gov/pubmed/16915382,10945867|16915382,,
178,1378327,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),Imidacloprid analog inhibits the reaction [nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]],,,PMID:10377228,https://www.ncbi.nlm.nih.gov/pubmed/10377228,10377228,,
179,1378328,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),Nicotine binds to [CHRNA4 protein binds to CHRNB2 protein]|nicotine analog binds to [CHRNA4 protein binds to CHRNB2 protein],,,PMID:15615518|PMID:19252481,https://www.ncbi.nlm.nih.gov/pubmed/15615518|https://www.ncbi.nlm.nih.gov/pubmed/19252481,15615518|19252481,,
180,1378329,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein],,,PMID:10377228|PMID:11150171,https://www.ncbi.nlm.nih.gov/pubmed/10377228|https://www.ncbi.nlm.nih.gov/pubmed/11150171,10377228|11150171,,
181,1378330,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),[nicotine co-treated with benzo(a)pyrene] results in decreased expression of [CHRNA4 protein binds to CHRNB2 protein],,,PMID:30247698,https://www.ncbi.nlm.nih.gov/pubmed/30247698,30247698,,
182,1378331,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),Nicotine results in decreased expression of CHRNB2 mRNA,,,PMID:20060465,https://www.ncbi.nlm.nih.gov/pubmed/20060465,20060465,,
183,1378332,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,10116,Rattus norvegicus (Norway rat),Nicotine results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein],,,PMID:16981889,https://www.ncbi.nlm.nih.gov/pubmed/16981889,16981889,,
184,1379031,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1382,CRABP2,https://ctdbase.org/detail.go?type=gene&acc=1382,,,1382.0,CRABP2,9606,Homo sapiens (human),Nicotine results in decreased expression of CRABP2 mRNA,,,PMID:16949557,https://www.ncbi.nlm.nih.gov/pubmed/16949557,16949557,,
185,1379032,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,9606,Homo sapiens (human),Nicotine results in increased phosphorylation of CREB1 protein|creb1 protein promotes the reaction [nicotine results in increased expression of MMP7 mrna],,,PMID:25847246,https://www.ncbi.nlm.nih.gov/pubmed/25847246,25847246,,
186,1379033,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,9606,Homo sapiens (human),Nicotine results in decreased expression of CREB1 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
187,1379034,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090,Mus musculus (house mouse),Nicotine results in increased expression of CREB1 mRNA,,,PMID:31945395,https://www.ncbi.nlm.nih.gov/pubmed/31945395,31945395,,
188,1379327,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1447,CSN2,https://ctdbase.org/detail.go?type=gene&acc=1447,,,1447.0,CSN2,10090,Mus musculus (house mouse),Nicotine results in decreased expression of and results in decreased secretion of CSN2 protein,,,PMID:31783125,https://www.ncbi.nlm.nih.gov/pubmed/31783125,31783125,,
189,1379328,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1457,CSNK2A1,https://ctdbase.org/detail.go?type=gene&acc=1457,,,1457.0,CSNK2A1,9606,Homo sapiens (human),CHRNA7 affects the reaction [nicotine results in increased expression of CSNK2A1 protein]|csnk2a1 affects the reaction [nicotine results in increased phosphorylation of AKT1 protein]|csnk2a1 affects the reaction [nicotine results in decreased expression of SLBP protein]|nicotine results in increased expression of CSNK2A1 protein,,,PMID:35929799,https://www.ncbi.nlm.nih.gov/pubmed/35929799,35929799,,
190,1379329,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1471,CST3,https://ctdbase.org/detail.go?type=gene&acc=1471,,,1471.0,CST3,10090,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CST3 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CST3 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
191,1379330,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10090,Mus musculus (house mouse),Carbon tetrachloride inhibits the reaction [nicotine results in decreased expression of CTNNB1 mrna]|nicotine inhibits the reaction [carbon tetrachloride results in decreased expression of CTNNB1 mrna],,,PMID:35411647,https://www.ncbi.nlm.nih.gov/pubmed/35411647,35411647,,
192,1379331,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10090,Mus musculus (house mouse),Nicotine results in increased expression of CTNNB1 protein|nicotine promotes the reaction [carbon tetrachloride results in increased expression of CTNNB1 mrna]|nicotine promotes the reaction [carbon tetrachloride results in increased expression of CTNNB1 protein],,,PMID:33640489,https://www.ncbi.nlm.nih.gov/pubmed/33640489,33640489,,
193,1379473,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10090,Mus musculus (house mouse),Nicotine results in increased expression of CTNNB1 mRNA,,,PMID:33640489|PMID:35411647,https://www.ncbi.nlm.nih.gov/pubmed/33640489|https://www.ncbi.nlm.nih.gov/pubmed/35411647,33640489|35411647,,
194,1379474,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10090,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CTSB mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CTSB mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
195,1379475,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1512,CTSH,https://ctdbase.org/detail.go?type=gene&acc=1512,,,1512.0,CTSH,9606,Homo sapiens (human),Nicotine results in increased expression of CTSH mRNA,,,PMID:23825647,https://www.ncbi.nlm.nih.gov/pubmed/23825647,23825647,,
196,1379476,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1514,CTSL,https://ctdbase.org/detail.go?type=gene&acc=1514,,,1514.0,CTSL,10090,Mus musculus (house mouse),"Nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CTSL mrna]|[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CTSL mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
197,1379477,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090,Mus musculus (house mouse),Nicotine results in decreased expression of CXCL1 mrna|nicotine results in decreased secretion of CXCL1 protein,,,PMID:22093924,https://www.ncbi.nlm.nih.gov/pubmed/22093924,22093924,,
198,1379478,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090,Mus musculus (house mouse),Nicotine results in increased expression of CXCL1 protein,,,PMID:16254210,https://www.ncbi.nlm.nih.gov/pubmed/16254210,16254210,,
199,1379479,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,9606,Homo sapiens (human),Nicotine results in decreased expression of CXCL2 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
200,1379480,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),"Nicotine promotes the reaction [lipopolysaccharides results in increased expression of CXCL8 mrna]|tubocurarine inhibits the reaction [nicotine promotes the reaction [IL1B protein results in increased expression of CXCL8 mrna]]|u 0126 inhibits the reaction [nicotine promotes the reaction [IL1B protein results in increased expression of CXCL8 protein]]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [nicotine promotes the reaction [IL1B protein results in increased expression of CXCL8 protein]]|nicotine promotes the reaction [IL1B protein results in increased expression of CXCL8 mrna]|nicotine promotes the reaction [IL1B protein results in increased secretion of CXCL8 protein]|tubocurarine inhibits the reaction [nicotine promotes the reaction [IL1B protein results in increased secretion of CXCL8 protein]]|nicotine promotes the reaction [IL1B protein results in increased expression of CXCL8 protein]",,,PMID:22119045,https://www.ncbi.nlm.nih.gov/pubmed/22119045,22119045,,
201,1379481,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [nicotine results in increased expression of CXCL8 mrna]|sr 11302 inhibits the reaction [nicotine results in increased expression of CXCL8 mrna]|sb 203580 inhibits the reaction [nicotine results in increased secretion of CXCL8 protein]|acetylcysteine inhibits the reaction [nicotine results in increased expression of CXCL8 mrna]|sr 11302 inhibits the reaction [nicotine results in increased secretion of CXCL8 protein]|diphenyleneiodonium inhibits the reaction [nicotine results in increased secretion of CXCL8 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [nicotine results in increased secretion of CXCL8 protein]|3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [nicotine results in increased expression of CXCL8 mrna]|3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [nicotine results in increased secretion of CXCL8 protein]|sb 203580 inhibits the reaction [nicotine results in increased expression of CXCL8 mrna]|acetylcysteine inhibits the reaction [nicotine results in increased secretion of CXCL8 protein]|nicotine results in increased expression of and results in increased secretion of CXCL8 protein|diphenyleneiodonium inhibits the reaction [nicotine results in increased expression of CXCL8 mrna],,,PMID:34890707,https://www.ncbi.nlm.nih.gov/pubmed/34890707,34890707,,
202,1379944,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1592,CYP26A1,https://ctdbase.org/detail.go?type=gene&acc=1592,,,1592.0,CYP26A1,9606,Homo sapiens (human),Nicotine results in decreased expression of CYP26A1 mrna|nicotine results in decreased expression of CYP26A1 protein,,,PMID:21371177,https://www.ncbi.nlm.nih.gov/pubmed/21371177,21371177,,
203,1380070,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,60711,Chlorocebus sabaeus (green monkey),Nicotine results in decreased expression of and results in decreased activity of CYP2A6 protein|[nicotine co-treated with ethanol] results in decreased expression of CYP2A6 mrna|nicotine results in decreased expression of CYP2A6 mrna|[nicotine co-treated with ethanol] results in decreased expression of and results in decreased activity of CYP2A6 protein,,,PMID:22935730,https://www.ncbi.nlm.nih.gov/pubmed/22935730,22935730,,
204,1380071,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),CYP2A6 exon SNP results in decreased oxidation of nicotine,,,PMID:11237731,https://www.ncbi.nlm.nih.gov/pubmed/11237731,11237731,,
205,1380072,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),CYP2A6 gene mutant form results in decreased metabolism of nicotine,,,PMID:10448083|PMID:10668854,https://www.ncbi.nlm.nih.gov/pubmed/10448083|https://www.ncbi.nlm.nih.gov/pubmed/10668854,10448083|10668854,,
206,1380073,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),CYP2A6 gene mutant form results in decreased oxidation of nicotine,,,PMID:20012030,https://www.ncbi.nlm.nih.gov/pubmed/20012030,20012030,,
207,1380074,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),CYP2A6 gene polymorphism affects the metabolism of and affects the abundance of nicotine,,,PMID:16141602,https://www.ncbi.nlm.nih.gov/pubmed/16141602,16141602,,
208,1380075,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),CYP2A6 gene polymorphism affects the metabolism of nicotine,,,PMID:11180041|PMID:11434509|PMID:16372023|PMID:16402086|PMID:16636685|PMID:16952495|PMID:22569203,https://www.ncbi.nlm.nih.gov/pubmed/11180041|https://www.ncbi.nlm.nih.gov/pubmed/11434509|https://www.ncbi.nlm.nih.gov/pubmed/16372023|https://www.ncbi.nlm.nih.gov/pubmed/16402086|https://www.ncbi.nlm.nih.gov/pubmed/16636685|https://www.ncbi.nlm.nih.gov/pubmed/16952495|https://www.ncbi.nlm.nih.gov/pubmed/22569203,11180041|11434509|16372023|16402086|16636685|16952495|22569203,,
209,1380076,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),CYP2A6 gene polymorphism affects the oxidation of nicotine,,,PMID:10663384|PMID:15900015,https://www.ncbi.nlm.nih.gov/pubmed/10663384|https://www.ncbi.nlm.nih.gov/pubmed/15900015,10663384|15900015,,
210,1381047,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606,Homo sapiens (human),MK-886 inhibits the reaction [nicotine results in increased expression of E2F1 protein]|nicotine results in increased expression of E2F1 protein,,,PMID:20061081,https://www.ncbi.nlm.nih.gov/pubmed/20061081,20061081,,
211,1381048,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606,Homo sapiens (human),Nicotine promotes the reaction [E2F1 protein binds to BIRC5 promoter],,,PMID:16601104,https://www.ncbi.nlm.nih.gov/pubmed/16601104,16601104,,
212,1381049,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606,Homo sapiens (human),Nicotine promotes the reaction [E2F1 protein binds to CDC6 promoter]|nicotine promotes the reaction [E2F1 protein binds to CDC25A promoter],,,PMID:16862215,https://www.ncbi.nlm.nih.gov/pubmed/16862215,16862215,,
213,1381527,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Nicotine results in increased expression of and results in increased phosphorylation of EIF4EBP1 protein|nicotine promotes the reaction [EIF4EBP1 protein binds to EIF4E protein],,,PMID:30836163,https://www.ncbi.nlm.nih.gov/pubmed/30836163,30836163,,
214,1381528,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),[nicotine results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of EIF4EBP1 protein,,,PMID:12511591,https://www.ncbi.nlm.nih.gov/pubmed/12511591,12511591,,
215,1381529,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1983,EIF5,https://ctdbase.org/detail.go?type=gene&acc=1983,,,1983.0,EIF5,10090,Mus musculus (house mouse),"[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of EIF5 mrna|nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of EIF5 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
216,1381530,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,2002,ELK1,https://ctdbase.org/detail.go?type=gene&acc=2002,,,2002.0,ELK1,9606,Homo sapiens (human),Vecuronium bromide inhibits the reaction [nicotine results in increased phosphorylation of ELK1 protein]|nicotine results in increased phosphorylation of ELK1 protein,,,PMID:29486207,https://www.ncbi.nlm.nih.gov/pubmed/29486207,29486207,,
217,1381531,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,10090,Mus musculus (house mouse),Nicotine results in decreased expression of EMC3 mRNA,,,PMID:17997037,https://www.ncbi.nlm.nih.gov/pubmed/17997037,17997037,,
218,1381532,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,51705,EMCN,https://ctdbase.org/detail.go?type=gene&acc=51705,,,51705.0,EMCN,10090,Mus musculus (house mouse),Nicotine results in increased expression of EMCN mRNA,,,PMID:17456735,https://www.ncbi.nlm.nih.gov/pubmed/17456735,17456735,,
219,1381533,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,27436,EML4,https://ctdbase.org/detail.go?type=gene&acc=27436,,,27436.0,EML4,9606,Homo sapiens (human),Tubocurarine inhibits the reaction [nicotine results in decreased expression of EML4 mrna]|mecamylamine promotes the reaction [nicotine results in decreased expression of EML4 mrna]|nicotine results in decreased expression of EML4 mrna|alpha-cobratoxin inhibits the reaction [nicotine results in decreased expression of EML4 mrna],,,PMID:12588870,https://www.ncbi.nlm.nih.gov/pubmed/12588870,12588870,,
220,1381534,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,2012,EMP1,https://ctdbase.org/detail.go?type=gene&acc=2012,,,2012.0,EMP1,9606,Homo sapiens (human),Nicotine results in increased expression of EMP1 mRNA,,,PMID:23825647,https://www.ncbi.nlm.nih.gov/pubmed/23825647,23825647,,
221,1381535,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,8507,ENC1,https://ctdbase.org/detail.go?type=gene&acc=8507,,,8507.0,ENC1,10090,Mus musculus (house mouse),Nicotine results in decreased expression of ENC1 mRNA,,,PMID:17997037,https://www.ncbi.nlm.nih.gov/pubmed/17997037,17997037,,
222,1454603,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090,Mus musculus (house mouse),Peptidoglycan results in increased secretion of CCL2 protein,,,PMID:15593098,https://www.ncbi.nlm.nih.gov/pubmed/15593098,15593098,,
223,1454604,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364.0,CCL20,9606,Homo sapiens (human),Peptidoglycan results in increased expression of CCL20 mRNA,,,PMID:15860229,https://www.ncbi.nlm.nih.gov/pubmed/15860229,15860229,,
224,1454605,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364.0,CCL20,9606,Homo sapiens (human),Peptidoglycan results in increased expression of CCL20 protein,,,PMID:15191912,https://www.ncbi.nlm.nih.gov/pubmed/15191912,15191912,,
225,1454606,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,64581,CLEC7A,https://ctdbase.org/detail.go?type=gene&acc=64581,,,64581.0,CLEC7A,9606,Homo sapiens (human),CLEC7A protein promotes the reaction [peptidoglycan results in increased metabolism of leukotriene C4],,,PMID:17030235,https://www.ncbi.nlm.nih.gov/pubmed/17030235,17030235,,
226,1378017,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3494,IGHA2,https://ctdbase.org/detail.go?type=gene&acc=3494,,,3494.0,IGHA2,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGHA2 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
227,1378018,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3502,IGHG3,https://ctdbase.org/detail.go?type=gene&acc=3502,,,3502.0,IGHG3,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGHG3 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
228,1378019,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,28448,IGHV3-15,https://ctdbase.org/detail.go?type=gene&acc=28448,,,28448.0,IGHV3-15,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGHV3-15 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
229,1378020,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,28412,IGHV3-66,https://ctdbase.org/detail.go?type=gene&acc=28412,,,28412.0,IGHV3-66,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGHV3-66 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
230,1378021,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,28388,IGHV5-51,https://ctdbase.org/detail.go?type=gene&acc=28388,,,28388.0,IGHV5-51,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGHV5-51 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
231,1378022,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,28943,IGKV1-6,https://ctdbase.org/detail.go?type=gene&acc=28943,,,28943.0,IGKV1-6,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGKV1-6 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
232,1378023,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,28896,IGKV1D-33,https://ctdbase.org/detail.go?type=gene&acc=28896,,,28896.0,IGKV1D-33,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IGKV1D-33 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
233,1380388,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,687,KLF9,https://ctdbase.org/detail.go?type=gene&acc=687,,,687.0,KLF9,90988,Pimephales promelas (fathead minnow),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KLF9 mRNA",,,PMID:19079722,https://www.ncbi.nlm.nih.gov/pubmed/19079722,19079722,,
234,1380389,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,687,KLF9,https://ctdbase.org/detail.go?type=gene&acc=687,,,687.0,KLF9,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of KLF9 mrna|[2,2',4,4'-tetrabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of KLF9 mRNA",,,PMID:21436126,https://www.ncbi.nlm.nih.gov/pubmed/21436126,21436126,,
235,1380390,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,317719,KLHL10,https://ctdbase.org/detail.go?type=gene&acc=317719,,,317719.0,KLHL10,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KLHL10 mRNA",,,PMID:28712647,https://www.ncbi.nlm.nih.gov/pubmed/28712647,28712647,,
236,1381695,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,84918,LRP11,https://ctdbase.org/detail.go?type=gene&acc=84918,,,84918.0,LRP11,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of LRP11 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
237,1377862,102614,Comparative Toxicogenomics Database (CTD),"2,3-Bis(4-hydroxyphenyl)propionitrile",C486182,"2,3-bis(4-hydroxyphenyl)-propionitrile",https://ctdbase.org/detail.go?type=chem&acc=C486182,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116,Rattus norvegicus (Norway rat),"[2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] which results in increased expression of SLC1A2 protein",,,PMID:24782323,https://www.ncbi.nlm.nih.gov/pubmed/24782323,24782323,,
238,1377863,102614,Comparative Toxicogenomics Database (CTD),"2,3-Bis(4-hydroxyphenyl)propionitrile",C486182,"2,3-bis(4-hydroxyphenyl)-propionitrile",https://ctdbase.org/detail.go?type=chem&acc=C486182,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116,Rattus norvegicus (Norway rat),"2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [estrogens deficiency results in increased expression of ESR2 protein alternative form]",,,PMID:30565903,https://www.ncbi.nlm.nih.gov/pubmed/30565903,30565903,,
239,1378333,102614,Comparative Toxicogenomics Database (CTD),"2,3-Bis(4-hydroxyphenyl)propionitrile",C486182,"2,3-bis(4-hydroxyphenyl)-propionitrile",https://ctdbase.org/detail.go?type=chem&acc=C486182,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),"2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [glucose results in decreased expression of SOD2 protein]]",,,PMID:20962025,https://www.ncbi.nlm.nih.gov/pubmed/20962025,20962025,,
240,1378334,102614,Comparative Toxicogenomics Database (CTD),"2,3-Bis(4-hydroxyphenyl)propionitrile",C486182,"2,3-bis(4-hydroxyphenyl)-propionitrile",https://ctdbase.org/detail.go?type=chem&acc=C486182,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),"2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SOD2 protein",,,PMID:21215799|PMID:23526725,https://www.ncbi.nlm.nih.gov/pubmed/21215799|https://www.ncbi.nlm.nih.gov/pubmed/23526725,21215799|23526725,,
241,1378335,102614,Comparative Toxicogenomics Database (CTD),"2,3-Bis(4-hydroxyphenyl)propionitrile",C486182,"2,3-bis(4-hydroxyphenyl)-propionitrile",https://ctdbase.org/detail.go?type=chem&acc=C486182,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),"ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SOD2 protein]",,,PMID:23526725,https://www.ncbi.nlm.nih.gov/pubmed/23526725,23526725,,
242,1378700,105104,IUPHAR/BPS Guide to PHARMACOLOGY,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",1656,[3H]U69593,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1656,318,κ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),Full agonist,pKd,8.7 - 8.8,PMID:7624359|PMID:2986999,https://www.ncbi.nlm.nih.gov/pubmed/7624359|https://www.ncbi.nlm.nih.gov/pubmed/2986999,7624359|2986999,,
243,1378701,105104,IUPHAR/BPS Guide to PHARMACOLOGY,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",1655,U69593,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1655,318,κ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318,P33534,Kappa-type opioid receptor,18387.0,Oprk1,10090,Mus musculus (house mouse),Full agonist,pIC50,8.6,PMID:8393575,https://www.ncbi.nlm.nih.gov/pubmed/8393575,8393575,,
244,1378702,105104,IUPHAR/BPS Guide to PHARMACOLOGY,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",1655,U69593,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1655,318,κ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318,P34975,Kappa-type opioid receptor,29335.0,Oprk1,10116,Rattus norvegicus (Norway rat),Full agonist,pKi,8 - 8.7,PMID:8240267|PMID:8234341,https://www.ncbi.nlm.nih.gov/pubmed/8240267|https://www.ncbi.nlm.nih.gov/pubmed/8234341,8240267|8234341,,
245,1379332,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of AP1M1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
246,1379333,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606,Homo sapiens (human),Melatonin inhibits the reaction [[glucose co-treated with deferoxamine] results in increased expression of APAF1 mrna]|[glucose co-treated with deferoxamine] results in increased expression of APAF1 mRNA,,,PMID:33962019,https://www.ncbi.nlm.nih.gov/pubmed/33962019,33962019,,
247,1379334,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,323,APBB2,https://ctdbase.org/detail.go?type=gene&acc=323,,,323.0,APBB2,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of APBB2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
248,1379335,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,324,APC,https://ctdbase.org/detail.go?type=gene&acc=324,,,324.0,APC,10116,Rattus norvegicus (Norway rat),Glucose results in decreased expression of APC mRNA,,,PMID:21818840,https://www.ncbi.nlm.nih.gov/pubmed/21818840,21818840,,
249,1379336,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in increased expression of APCS mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
250,1471452,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,9927,MFN2,https://ctdbase.org/detail.go?type=gene&acc=9927,,,9927.0,MFN2,10116,Rattus norvegicus (Norway rat),Perindopril results in increased expression of MFN2 mrna|perindopril results in increased expression of MFN2 protein,,,PMID:25464244,https://www.ncbi.nlm.nih.gov/pubmed/25464244,25464244,,
251,1471453,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090,Mus musculus (house mouse),Perindopril inhibits the reaction [diethylnitrosamine results in increased expression of MMP2 protein],,,PMID:29859236,https://www.ncbi.nlm.nih.gov/pubmed/29859236,29859236,,
252,1471454,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116,Rattus norvegicus (Norway rat),Perindopril inhibits the reaction [carbon tetrachloride results in increased activity of MMP2 protein],,,PMID:12930639|PMID:14761280|PMID:16097048,https://www.ncbi.nlm.nih.gov/pubmed/12930639|https://www.ncbi.nlm.nih.gov/pubmed/14761280|https://www.ncbi.nlm.nih.gov/pubmed/16097048,12930639|14761280|16097048,,
253,1471455,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10116,Rattus norvegicus (Norway rat),Perindopril inhibits the reaction [carbon tetrachloride results in increased activity of MMP9 protein],,,PMID:16097048,https://www.ncbi.nlm.nih.gov/pubmed/16097048,16097048,,
254,1471456,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Perindopril results in decreased expression of TNF protein,,,PMID:19840533,https://www.ncbi.nlm.nih.gov/pubmed/19840533,19840533,,
255,1471457,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4360,MRC1,https://ctdbase.org/detail.go?type=gene&acc=4360,,,4360.0,MRC1,10090,Mus musculus (house mouse),AM6545 promotes the reaction [perindopril inhibits the reaction [streptozocin results in decreased expression of MRC1 mrna]]|perindopril inhibits the reaction [streptozocin results in decreased expression of MRC1 mrna]|perindopril promotes the reaction [AM6545 inhibits the reaction [streptozocin results in decreased expression of MRC1 mrna]],,,PMID:30184259,https://www.ncbi.nlm.nih.gov/pubmed/30184259,30184259,,
256,1471458,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090,Mus musculus (house mouse),Perindopril inhibits the reaction [diethylnitrosamine results in decreased expression of NFKB1 protein],,,PMID:29859236,https://www.ncbi.nlm.nih.gov/pubmed/29859236,29859236,,
257,1471459,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Perindopril inhibits the reaction [streptozocin results in increased expression of NOS2 mrna]|am6545 promotes the reaction [perindopril inhibits the reaction [streptozocin results in increased expression of NOS2 mrna]]|perindopril promotes the reaction [AM6545 inhibits the reaction [streptozocin results in increased expression of NOS2 mrna]],,,PMID:30184259,https://www.ncbi.nlm.nih.gov/pubmed/30184259,30184259,,
258,1471460,107807,Comparative Toxicogenomics Database (CTD),Perindopril,D020913,Perindopril,https://ctdbase.org/detail.go?type=chem&acc=D020913,4868,NPHS1,https://ctdbase.org/detail.go?type=gene&acc=4868,,,4868.0,NPHS1,10090,Mus musculus (house mouse),AM6545 promotes the reaction [perindopril inhibits the reaction [streptozocin results in decreased expression of NPHS1 mrna]]|perindopril promotes the reaction [AM6545 inhibits the reaction [streptozocin results in decreased expression of NPHS1 mrna]]|perindopril inhibits the reaction [streptozocin results in decreased expression of NPHS1 mrna]|perindopril promotes the reaction [AM6545 inhibits the reaction [streptozocin results in decreased expression of NPHS1 protein]]|am6545 promotes the reaction [perindopril inhibits the reaction [streptozocin results in decreased expression of NPHS1 protein]]|perindopril inhibits the reaction [streptozocin results in decreased expression of NPHS1 protein],,,PMID:30184259,https://www.ncbi.nlm.nih.gov/pubmed/30184259,30184259,,
259,1381384,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,23162,MAPK8IP3,https://ctdbase.org/detail.go?type=gene&acc=23162,,,23162.0,MAPK8IP3,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAPK8IP3 gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
260,1381385,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,79648,MCPH1,https://ctdbase.org/detail.go?type=gene&acc=79648,,,79648.0,MCPH1,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MCPH1 gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
261,1381386,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,2872,MKNK2,https://ctdbase.org/detail.go?type=gene&acc=2872,,,2872.0,MKNK2,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MKNK2 gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
262,1381387,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,55233,MOB1A,https://ctdbase.org/detail.go?type=gene&acc=55233,,,55233.0,MOB1A,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MOB1A gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
263,1381388,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,4628,MYH10,https://ctdbase.org/detail.go?type=gene&acc=4628,,,4628.0,MYH10,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MYH10 gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
264,1381389,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,79784,MYH14,https://ctdbase.org/detail.go?type=gene&acc=79784,,,79784.0,MYH14,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MYH14 gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
265,1381390,107885,Comparative Toxicogenomics Database (CTD),11-Nor-9-carboxy-thc,C016780,11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C016780,4638,MYLK,https://ctdbase.org/detail.go?type=gene&acc=4638,,,4638.0,MYLK,9606,Homo sapiens (human),[cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MYLK gene,,,PMID:30521419,https://www.ncbi.nlm.nih.gov/pubmed/30521419,30521419,,
266,1431085,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of FOS mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
267,1431086,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,2354,FOSB,https://ctdbase.org/detail.go?type=gene&acc=2354,,,2354.0,FOSB,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of FOSB mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
268,1431087,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,3169,FOXA1,https://ctdbase.org/detail.go?type=gene&acc=3169,,,3169.0,FOXA1,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of FOXA1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
269,1431088,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,3170,FOXA2,https://ctdbase.org/detail.go?type=gene&acc=3170,,,3170.0,FOXA2,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of FOXA2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
270,1530047,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,6921,ELOC,https://ctdbase.org/detail.go?type=gene&acc=6921,,,6921.0,ELOC,10116,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of ELOC mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
271,1530048,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,2023,ENO1,https://ctdbase.org/detail.go?type=gene&acc=2023,,,2023.0,ENO1,10116,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of ENO1 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
272,1470665,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0002282,Microsomal glutathione S-transferase 1,https://www.drugbank.ca/bio_entities/BE0002282,P10620,Microsomal glutathione S-transferase 1,4257.0,MGST1,9606,Homo sapiens (human),,,,PMID:17306223|PMID:17297922,https://www.ncbi.nlm.nih.gov/pubmed/17306223|https://www.ncbi.nlm.nih.gov/pubmed/17297922,17306223|17297922,,
273,1470666,124886,DrugBank,Glutathione,DB00143,Glutathione,https://www.drugbank.ca/drugs/DB00143,BE0002283,S-formylglutathione hydrolase,https://www.drugbank.ca/bio_entities/BE0002283,P10768,S-formylglutathione hydrolase,2098.0,ESD,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:12904537|PMID:7397203|PMID:2554783,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/12904537|https://www.ncbi.nlm.nih.gov/pubmed/7397203|https://www.ncbi.nlm.nih.gov/pubmed/2554783,17139284|17016423|12904537|7397203|2554783,,
274,1379628,126941,DrugBank,Methotrexate,DB00563,Methotrexate,https://www.drugbank.ca/drugs/DB00563,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606,Homo sapiens (human),Substrate,,,PMID:11375950,https://www.ncbi.nlm.nih.gov/pubmed/11375950,11375950,,
275,1379629,126941,DrugBank,Methotrexate,DB00563,Methotrexate,https://www.drugbank.ca/drugs/DB00563,BE0000879,Solute carrier family 22 member 11,https://www.drugbank.ca/bio_entities/BE0000879,Q9NSA0,Solute carrier family 22 member 11,55867.0,SLC22A11,9606,Homo sapiens (human),Substrate,,,PMID:12130730,https://www.ncbi.nlm.nih.gov/pubmed/12130730,12130730,,
276,1379630,126941,DrugBank,Methotrexate,DB00563,Methotrexate,https://www.drugbank.ca/drugs/DB00563,BE0003660,Solute carrier organic anion transporter family member 1C1,https://www.drugbank.ca/bio_entities/BE0003660,Q9NYB5,Solute carrier organic anion transporter family member 1C1,53919.0,SLCO1C1,9606,Homo sapiens (human),Substrate,,,PMID:12351693,https://www.ncbi.nlm.nih.gov/pubmed/12351693,12351693,,
277,1470490,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5360,PLTP,https://ctdbase.org/detail.go?type=gene&acc=5360,,,5360.0,PLTP,9606,Homo sapiens (human),Methotrexate results in increased expression of PLTP mRNA,,,PMID:17379860,https://www.ncbi.nlm.nih.gov/pubmed/17379860,17379860,,
278,1470491,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5360,PLTP,https://ctdbase.org/detail.go?type=gene&acc=5360,,,5360.0,PLTP,10090,Mus musculus (house mouse),Methotrexate affects the expression of PLTP mrna|methotrexate results in decreased expression of PLTP mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
279,1470492,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,10090,Mus musculus (house mouse),Methotrexate affects the expression of PLXNA2 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
280,1470493,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5364,PLXNB1,https://ctdbase.org/detail.go?type=gene&acc=5364,,,5364.0,PLXNB1,9606,Homo sapiens (human),Methotrexate results in increased expression of PLXNB1 mRNA,,,PMID:17400583|PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/17400583|https://www.ncbi.nlm.nih.gov/pubmed/21678067,17400583|21678067,,
281,1470494,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606,Homo sapiens (human),ESRRA protein inhibits the reaction [methotrexate results in increased expression of PMAIP1 mrna],,,PMID:24967384,https://www.ncbi.nlm.nih.gov/pubmed/24967384,24967384,,
282,1470495,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606,Homo sapiens (human),Methotrexate results in increased expression of PMAIP1 mRNA,,,PMID:21114963|PMID:21678067|PMID:24967384,https://www.ncbi.nlm.nih.gov/pubmed/21114963|https://www.ncbi.nlm.nih.gov/pubmed/21678067|https://www.ncbi.nlm.nih.gov/pubmed/24967384,21114963|21678067|24967384,,
283,1470496,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,11243,PMF1,https://ctdbase.org/detail.go?type=gene&acc=11243,,,11243.0,PMF1,10090,Mus musculus (house mouse),Methotrexate affects the expression of PMF1 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
284,1470497,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5378,PMS1,https://ctdbase.org/detail.go?type=gene&acc=5378,,,5378.0,PMS1,10090,Mus musculus (house mouse),Methotrexate affects the expression of PMS1 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
285,1470498,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,5406,PNLIP,https://ctdbase.org/detail.go?type=gene&acc=5406,,,5406.0,PNLIP,10090,Mus musculus (house mouse),Methotrexate affects the expression of PNLIP mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
286,1379762,127887,Comparative Toxicogenomics Database (CTD),Fluoroclebopride,C083673,fluoroclebopride,https://ctdbase.org/detail.go?type=chem&acc=C083673,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813.0,DRD2,9544,Macaca mulatta (Rhesus monkey),Fluoroclebopride binds to DRD2 protein,,,PMID:10638823,https://www.ncbi.nlm.nih.gov/pubmed/10638823,10638823,,
287,1379763,127887,Comparative Toxicogenomics Database (CTD),Fluoroclebopride,C083673,fluoroclebopride,https://ctdbase.org/detail.go?type=chem&acc=C083673,1814,DRD3,https://ctdbase.org/detail.go?type=gene&acc=1814,,,1814.0,DRD3,9544,Macaca mulatta (Rhesus monkey),[fluoroclebopride binds to and results in decreased activity of DRD3 protein] which affects the susceptibility to cocaine|fluoroclebopride binds to and results in decreased activity of DRD3 protein,,,PMID:10591881,https://www.ncbi.nlm.nih.gov/pubmed/10591881,10591881,,
288,1379764,127894,Therapeutic Target Database (TTD),Tezampanel,D0B0NQ,LY293558,https://idrblab.net/ttd/data/drug/details/D0B0NQ,T73495,Glutamate receptor ionotropic kainate 1 (GRIK1),https://idrblab.net/ttd/data/target/details/T73495,P39086,"Glutamate receptor ionotropic, kainate 1",2897.0,GRIK1,9606,Homo sapiens (human),Modulator,,,,,,,
289,1472361,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0000248,Arachidonate 5-lipoxygenase,https://www.drugbank.ca/bio_entities/BE0000248,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606,Homo sapiens (human),,,,PMID:11752352|PMID:17015640,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/17015640,11752352|17015640,,
290,1472362,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0000262,Prostaglandin G/H synthase 2,https://www.drugbank.ca/bio_entities/BE0000262,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),,,,PMID:17015640,https://www.ncbi.nlm.nih.gov/pubmed/17015640,17015640,,
291,1472363,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0003768,Group IIE secretory phospholipase A2,https://www.drugbank.ca/bio_entities/BE0003768,Q9NZK7,Group IIE secretory phospholipase A2,30814.0,PLA2G2E,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
292,1472364,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606,Homo sapiens (human),Substrate,,,PMID:19515014,https://www.ncbi.nlm.nih.gov/pubmed/19515014,19515014,,
293,1472365,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:19515014|PMID:18268076,https://www.ncbi.nlm.nih.gov/pubmed/19515014|https://www.ncbi.nlm.nih.gov/pubmed/18268076,19515014|18268076,,
294,1472366,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0003683,Cytochrome P450 2J2,https://www.drugbank.ca/bio_entities/BE0003683,P51589,Cytochrome P450 2J2,1573.0,CYP2J2,9606,Homo sapiens (human),Substrate,,,PMID:19515014,https://www.ncbi.nlm.nih.gov/pubmed/19515014,19515014,,
295,1472367,133021,DrugBank,Licofelone,DB04725,Licofelone,https://www.drugbank.ca/drugs/DB04725,BE0003677,UDP-glucuronosyltransferase 1-3,https://www.drugbank.ca/bio_entities/BE0003677,P35503,UDP-glucuronosyltransferase 1A3,54659.0,UGT1A3,9606,Homo sapiens (human),Substrate,,,PMID:19515014,https://www.ncbi.nlm.nih.gov/pubmed/19515014,19515014,,
296,1472368,133966,Therapeutic Target Database (TTD),4-[(4-Cyanophenyl)-imidazol-1-ylmethyl]benzonitrile,D0V1UY,CGS-18320B,https://idrblab.net/ttd/data/drug/details/D0V1UY,T13260,Aromatase (CYP19A1),https://idrblab.net/ttd/data/target/details/T13260,P11511,Aromatase,1588.0,CYP19A1,9606,Homo sapiens (human),Inhibitor,,,,,,,
297,1380710,134780,BindingDB,Pomalidomide,65456,19171-19-8,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456,6,DNA damage-binding protein 1/Protein cereblon,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=6,Q16531,DNA damage-binding protein 1,1642.0,DDB1,9606,Homo sapiens (human),,IC50 (nM),3000,PMID:22552008|DOI:10.1038/leu.2012.119,https://www.ncbi.nlm.nih.gov/pubmed/22552008|https://doi.org/10.1038/leu.2012.119,22552008,10.1038/leu.2012.119,
298,1380711,135242,Therapeutic Target Database (TTD),Tilarginine Acetate,D06OQI,Tilarginine acetate,https://idrblab.net/ttd/data/drug/details/D06OQI,T06046,Nitric-oxide synthase endothelial (NOS3),https://idrblab.net/ttd/data/target/details/T06046,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606,Homo sapiens (human),Modulator,,,,,,,
299,1381686,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Arsenic trioxide promotes the reaction [tetraarsenic tetrasulfide results in increased cleavage of CASP3 protein]|arsenic trioxide promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of CASP3 mrna]|tetraarsenic tetrasulfide promotes the reaction [arsenic trioxide results in decreased expression of CASP3 mrna]|tetraarsenic tetrasulfide promotes the reaction [arsenic trioxide results in increased cleavage of CASP3 protein]|tetraarsenic tetrasulfide results in increased cleavage of CASP3 protein|tetraarsenic tetrasulfide results in decreased expression of CASP3 mRNA,,,PMID:26110921,https://www.ncbi.nlm.nih.gov/pubmed/26110921,26110921,,
300,1381687,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),[tetraarsenic tetrasulfide co-treated with imatinib mesylate] results in increased expression of CASP8 mRNA,,,PMID:19208803,https://www.ncbi.nlm.nih.gov/pubmed/19208803,19208803,,
301,1381688,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,867,CBL,https://ctdbase.org/detail.go?type=gene&acc=867,,,867.0,CBL,9606,Homo sapiens (human),Tetraarsenic tetrasulfide results in increased expression of CBL mrna|[tetraarsenic tetrasulfide co-treated with imatinib mesylate] results in increased expression of CBL mRNA,,,PMID:19208803,https://www.ncbi.nlm.nih.gov/pubmed/19208803,19208803,,
302,1381689,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606,Homo sapiens (human),[imatinib mesylate co-treated with tetraarsenic tetrasulfide] results in decreased expression of CCNA2 mRNA,,,PMID:19208803,https://www.ncbi.nlm.nih.gov/pubmed/19208803,19208803,,
303,1381690,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Tetraarsenic tetrasulfide results in decreased expression of CCND1 protein,,,PMID:26586936,https://www.ncbi.nlm.nih.gov/pubmed/26586936,26586936,,
304,1381691,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606,Homo sapiens (human),[imatinib mesylate co-treated with tetraarsenic tetrasulfide] results in decreased expression of CCND3 mRNA,,,PMID:19208803,https://www.ncbi.nlm.nih.gov/pubmed/19208803,19208803,,
305,1381692,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606,Homo sapiens (human),[imatinib mesylate co-treated with tetraarsenic tetrasulfide] results in decreased expression of CDK1 mRNA,,,PMID:19208803,https://www.ncbi.nlm.nih.gov/pubmed/19208803,19208803,,
306,1381693,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090,Mus musculus (house mouse),[tanshinone co-treated with indirubin] promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of CDK2 protein]|tetraarsenic tetrasulfide results in decreased expression of CDK2 protein|[tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased expression of CDK2 protein],,,PMID:18344322,https://www.ncbi.nlm.nih.gov/pubmed/18344322,18344322,,
307,1381694,139298,Comparative Toxicogenomics Database (CTD),Tetraarsenic tetrasulfide,C534735,tetraarsenic tetrasulfide,https://ctdbase.org/detail.go?type=chem&acc=C534735,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606,Homo sapiens (human),[imatinib mesylate co-treated with tetraarsenic tetrasulfide] results in decreased expression of CDK4 mRNA,,,PMID:19208803,https://www.ncbi.nlm.nih.gov/pubmed/19208803,19208803,,
308,1444847,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10090,Mus musculus (house mouse),Bazedoxifene affects the reaction [oxygen deficiency affects the expression of CYP19A1 mrna],,,PMID:28859903,https://www.ncbi.nlm.nih.gov/pubmed/28859903,28859903,,
309,1444848,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),CYP2C9 protein results in increased glutathionylation of bazedoxifene,,,PMID:22429462,https://www.ncbi.nlm.nih.gov/pubmed/22429462,22429462,,
310,1499364,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,3597,IL13RA1,https://ctdbase.org/detail.go?type=gene&acc=3597,,,3597.0,IL13RA1,9606,Homo sapiens (human),Torcetrapib results in increased expression of IL13RA1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
311,1499365,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,3572,IL6ST,https://ctdbase.org/detail.go?type=gene&acc=3572,,,3572.0,IL6ST,9606,Homo sapiens (human),Torcetrapib results in increased expression of IL6ST mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
312,1499366,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,3609,ILF3,https://ctdbase.org/detail.go?type=gene&acc=3609,,,3609.0,ILF3,9606,Homo sapiens (human),Torcetrapib results in increased expression of ILF3 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
313,1499367,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,54556,ING3,https://ctdbase.org/detail.go?type=gene&acc=54556,,,54556.0,ING3,9606,Homo sapiens (human),Torcetrapib results in increased expression of ING3 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
314,1471278,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,9606,Homo sapiens (human),Abrine results in decreased expression of ALAD mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
315,1471279,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,9606,Homo sapiens (human),Abrine results in decreased expression of ALCAM protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
316,1471280,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,126133,ALDH16A1,https://ctdbase.org/detail.go?type=gene&acc=126133,,,126133.0,ALDH16A1,9606,Homo sapiens (human),Abrine results in decreased expression of ALDH16A1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
317,1471281,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5832,ALDH18A1,https://ctdbase.org/detail.go?type=gene&acc=5832,,,5832.0,ALDH18A1,9606,Homo sapiens (human),Abrine results in decreased expression of ALDH18A1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
318,1471282,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,9606,Homo sapiens (human),Abrine results in decreased expression of ALDH1A1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
319,1471283,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,220,ALDH1A3,https://ctdbase.org/detail.go?type=gene&acc=220,,,220.0,ALDH1A3,9606,Homo sapiens (human),Abrine results in increased expression of ALDH1A3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
320,1471284,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,9606,Homo sapiens (human),Abrine results in decreased expression of ALDH1B1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
321,1471285,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,160428,ALDH1L2,https://ctdbase.org/detail.go?type=gene&acc=160428,,,160428.0,ALDH1L2,9606,Homo sapiens (human),Abrine results in decreased expression of ALDH1L2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
322,1471286,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606,Homo sapiens (human),Abrine results in increased expression of ALDH2 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
323,1471287,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,224,ALDH3A2,https://ctdbase.org/detail.go?type=gene&acc=224,,,224.0,ALDH3A2,9606,Homo sapiens (human),Abrine results in decreased expression of ALDH3A2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
324,1472034,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,284,ANGPT1,https://ctdbase.org/detail.go?type=gene&acc=284,,,284.0,ANGPT1,10090,Mus musculus (house mouse),Abrine results in increased expression of ANGPT1 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
325,1470991,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,9606,Homo sapiens (human),SB 203580 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mrna],,,PMID:37315771,https://www.ncbi.nlm.nih.gov/pubmed/37315771,37315771,,
326,1470992,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6574,SLC20A1,https://ctdbase.org/detail.go?type=gene&acc=6574,,,6574.0,SLC20A1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC20A1 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
327,1470993,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6530,SLC6A2,https://ctdbase.org/detail.go?type=gene&acc=6530,,,6530.0,SLC6A2,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [cocaine results in increased expression of SLC6A2 protein],,,PMID:25724654,https://www.ncbi.nlm.nih.gov/pubmed/25724654,25724654,,
328,1470994,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6541,SLC7A1,https://ctdbase.org/detail.go?type=gene&acc=6541,,,6541.0,SLC7A1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
329,1471612,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606,Homo sapiens (human),SB 203580 inhibits the reaction [LEP protein inhibits the reaction [8-bromo cyclic adenosine monophosphate results in increased expression of STAR protein]],,,PMID:19849856,https://www.ncbi.nlm.nih.gov/pubmed/19849856,19849856,,
330,1471613,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [SB 203580 results in increased expression of STAR mrna]|sb 203580 results in increased expression of STAR protein|sb 203580 promotes the reaction [8-bromo cyclic adenosine monophosphate results in increased expression of STAR protein]|sb 203580 promotes the reaction [8-bromo cyclic adenosine monophosphate results in increased expression of STAR mrna]|sb 203580 promotes the reaction [sodium arsenite results in increased expression of STAR protein]|sb 203580 promotes the reaction [sodium arsenite results in increased expression of STAR mrna]|sb 203580 results in increased expression of STAR mrna|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [SB 203580 promotes the reaction [sodium arsenite results in increased expression of STAR mrna]],,,PMID:15713539,https://www.ncbi.nlm.nih.gov/pubmed/15713539,15713539,,
331,1471614,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [perfluorooctane sulfonic acid inhibits the reaction [[CRTC2 protein binds to CREB1 protein modified form] which binds to STAR promoter]]|[n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with SB 203580] inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of STAR protein]|sb 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of STAR protein]|[n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with SB 203580] inhibits the reaction [perfluorooctane sulfonic acid inhibits the reaction [[CRTC2 protein binds to CREB1 protein modified form] which binds to STAR promoter]],,,PMID:33359577,https://www.ncbi.nlm.nih.gov/pubmed/33359577,33359577,,
332,1471615,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [nickel sulfate results in decreased expression of STAR mrna]|sb 203580 inhibits the reaction [nickel sulfate results in decreased expression of STAR protein],,,PMID:29567110,https://www.ncbi.nlm.nih.gov/pubmed/29567110,29567110,,
333,1471616,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein],,,PMID:16355272,https://www.ncbi.nlm.nih.gov/pubmed/16355272,16355272,,
334,1471897,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8835,SOCS2,https://ctdbase.org/detail.go?type=gene&acc=8835,,,8835.0,SOCS2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SOCS2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
335,1471898,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SOD1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
336,1471899,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6654,SOS1,https://ctdbase.org/detail.go?type=gene&acc=6654,,,6654.0,SOS1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl affects the expression of SOS1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
337,1471900,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,50964,SOST,https://ctdbase.org/detail.go?type=gene&acc=50964,,,50964.0,SOST,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SOST mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
338,1471901,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,25928,SOSTDC1,https://ctdbase.org/detail.go?type=gene&acc=25928,,,25928.0,SOSTDC1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SOSTDC1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
339,1471902,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SOX2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
340,1471903,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,53340,SPA17,https://ctdbase.org/detail.go?type=gene&acc=53340,,,53340.0,SPA17,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SPA17 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
341,1471904,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,6240,RRM1,https://ctdbase.org/detail.go?type=gene&acc=6240,,,6240.0,RRM1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RRM1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
342,1471905,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,51018,RRP15,https://ctdbase.org/detail.go?type=gene&acc=51018,,,51018.0,RRP15,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RRP15 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
343,1472691,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,23433,RHOQ,https://ctdbase.org/detail.go?type=gene&acc=23433,,,23433.0,RHOQ,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHOQ mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
344,1472692,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,89941,RHOT2,https://ctdbase.org/detail.go?type=gene&acc=89941,,,89941.0,RHOT2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHOT2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
345,1472693,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,85415,RHPN2,https://ctdbase.org/detail.go?type=gene&acc=85415,,,85415.0,RHPN2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RHPN2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
346,1433598,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of RPL23 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
347,1433599,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6147,RPL23A,https://ctdbase.org/detail.go?type=gene&acc=6147,,,6147.0,RPL23A,9031,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of RPL23A protein|aflatoxin B1 results in decreased expression of RPL23A protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
348,1433600,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56969,RPL23AP32,https://ctdbase.org/detail.go?type=gene&acc=56969,,,56969.0,RPL23AP32,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RPL23AP32 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
349,1492208,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,157922,CAMSAP1,https://ctdbase.org/detail.go?type=gene&acc=157922,,,157922.0,CAMSAP1,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CAMSAP1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
350,1492209,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,157922,CAMSAP1,https://ctdbase.org/detail.go?type=gene&acc=157922,,,157922.0,CAMSAP1,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CAMSAP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
351,1530045,261004,DrugBank,Arsenic(III) oxide,DB01169,Arsenic trioxide,https://www.drugbank.ca/drugs/DB01169,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Inhibitor,,,PMID:15833926|PMID:16184197,https://www.ncbi.nlm.nih.gov/pubmed/15833926|https://www.ncbi.nlm.nih.gov/pubmed/16184197,15833926|16184197,,
352,1530046,261004,DrugBank,Arsenic(III) oxide,DB01169,Arsenic trioxide,https://www.drugbank.ca/drugs/DB01169,BE0001069,Canalicular multispecific organic anion transporter 1,https://www.drugbank.ca/bio_entities/BE0001069,Q92887,Canalicular multispecific organic anion transporter 1,1244.0,ABCC2,9606,Homo sapiens (human),Inducer,,,PMID:11836020,https://www.ncbi.nlm.nih.gov/pubmed/11836020,11836020,,
353,1470326,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2563,GABRD,https://ctdbase.org/detail.go?type=gene&acc=2563,,,2563.0,GABRD,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of GABRD mRNA,,,PMID:19651682,https://www.ncbi.nlm.nih.gov/pubmed/19651682,19651682,,
354,1470327,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2566,GABRG2,https://ctdbase.org/detail.go?type=gene&acc=2566,,,2566.0,GABRG2,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA6 protein binds to GABRB2 protein binds to GABRG2 protein]]|bicuculline inhibits the reaction [methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA6 protein binds to GABRB2 protein binds to GABRG2 protein]]]|bicuculline inhibits the reaction [methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]]|methylmercuric chloride promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]],,,PMID:27720918,https://www.ncbi.nlm.nih.gov/pubmed/27720918,27720918,,
355,1470328,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55879,GABRQ,https://ctdbase.org/detail.go?type=gene&acc=55879,,,55879.0,GABRQ,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of GABRQ mRNA,,,PMID:21385734,https://www.ncbi.nlm.nih.gov/pubmed/21385734,21385734,,
356,1470329,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2571,GAD1,https://ctdbase.org/detail.go?type=gene&acc=2571,,,2571.0,GAD1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of GAD1 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
357,1471107,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,182080,SRX-78,https://ctdbase.org/detail.go?type=gene&acc=182080,,,182080.0,srx-78,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of SRX-78 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
358,1471108,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184316,SRX-92,https://ctdbase.org/detail.go?type=gene&acc=184316,,,184316.0,srx-92,6239,Caenorhabditis elegans,SRX-92 protein results in increased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of SRX-92 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
359,1472182,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,93953,GCNA,https://ctdbase.org/detail.go?type=gene&acc=93953,,,93953.0,GCNA,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of GCNA mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
360,1472183,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2650,GCNT1,https://ctdbase.org/detail.go?type=gene&acc=2650,,,2650.0,GCNT1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of GCNT1 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
361,1472184,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,324510,GCNT4A,https://ctdbase.org/detail.go?type=gene&acc=324510,,,324510.0,gcnt4a,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of GCNT4A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
362,1472185,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180386,GCP-2.1,https://ctdbase.org/detail.go?type=gene&acc=180386,,,180386.0,gcp-2.1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of GCP-2.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
363,1472529,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173624,F08D12.4,https://ctdbase.org/detail.go?type=gene&acc=173624,,,173624.0,F08D12.4,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F08D12.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
364,1472530,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178924,F08F3.4,https://ctdbase.org/detail.go?type=gene&acc=178924,,,178924.0,F08F3.4,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F08F3.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
365,1472531,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184198,F08F8.6,https://ctdbase.org/detail.go?type=gene&acc=184198,,,184198.0,F08F8.6,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F08F8.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
366,1472532,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184201,F08G2.5,https://ctdbase.org/detail.go?type=gene&acc=184201,,,184201.0,F08G2.5,6239,Caenorhabditis elegans,F08G2.5 protein results in increased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of F08G2.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
367,1472533,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184214,F08H9.3,https://ctdbase.org/detail.go?type=gene&acc=184214,,,184214.0,F08H9.3,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F08H9.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
368,1472534,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184215,F08H9.4,https://ctdbase.org/detail.go?type=gene&acc=184215,,,184215.0,F08H9.4,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F08H9.4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
369,1472535,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173881,F09C12.8,https://ctdbase.org/detail.go?type=gene&acc=173881,,,173881.0,F09C12.8,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F09C12.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
370,1472536,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184232,F09C6.3,https://ctdbase.org/detail.go?type=gene&acc=184232,,,184232.0,F09C6.3,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F09C6.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
371,1472537,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181691,F09C8.1,https://ctdbase.org/detail.go?type=gene&acc=181691,,,181691.0,F09C8.1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F09C8.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
372,1472538,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180487,F09E10.6,https://ctdbase.org/detail.go?type=gene&acc=180487,,,180487.0,F09E10.6,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F09E10.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
373,1446664,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of ICAM1 mrna]],,,PMID:20863785,https://www.ncbi.nlm.nih.gov/pubmed/20863785,20863785,,
374,1446665,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]],,,PMID:10946302,https://www.ncbi.nlm.nih.gov/pubmed/10946302,10946302,,
375,1446666,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mrna]]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of CCR1 mrna]]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of CCR2 mrna]]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of CCL4 mrna]]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of CCL3 mrna]]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of CCR5 mrna]],,,PMID:16321392,https://www.ncbi.nlm.nih.gov/pubmed/16321392,16321392,,
376,1446667,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [IFNG results in increased expression of HLA-DRA protein]],,,PMID:11219190,https://www.ncbi.nlm.nih.gov/pubmed/11219190,11219190,,
377,1470157,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Hesperidin inhibits the reaction [sodium arsenite results in increased activity of GPT protein],,,PMID:30066062,https://www.ncbi.nlm.nih.gov/pubmed/30066062,30066062,,
378,1470158,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Plant extracts inhibits the reaction [sodium arsenite results in increased expression of GPT protein],,,PMID:29736388,https://www.ncbi.nlm.nih.gov/pubmed/29736388,29736388,,
379,1470159,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),[[sodium arsenite results in increased abundance of arsenic] co-treated with [sodium fluoride results in increased abundance of fluorides]] results in decreased activity of GPT protein,,,PMID:33609566,https://www.ncbi.nlm.nih.gov/pubmed/33609566,33609566,,
380,1470160,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),[sodium arsenite results in increased abundance of arsenic] which results in increased activity of GPT protein,,,PMID:32402895|PMID:33026618,https://www.ncbi.nlm.nih.gov/pubmed/32402895|https://www.ncbi.nlm.nih.gov/pubmed/33026618,32402895|33026618,,
381,1470161,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased activity of GPT protein,,,PMID:30066062|PMID:34251737,https://www.ncbi.nlm.nih.gov/pubmed/30066062|https://www.ncbi.nlm.nih.gov/pubmed/34251737,30066062|34251737,,
382,1470162,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GPT protein,,,PMID:27174133|PMID:29459688|PMID:29736388|PMID:29935397,https://www.ncbi.nlm.nih.gov/pubmed/27174133|https://www.ncbi.nlm.nih.gov/pubmed/29459688|https://www.ncbi.nlm.nih.gov/pubmed/29736388|https://www.ncbi.nlm.nih.gov/pubmed/29935397,27174133|29459688|29736388|29935397,,
383,1470163,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84706,GPT2,https://ctdbase.org/detail.go?type=gene&acc=84706,,,84706.0,GPT2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GPT2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
384,1470320,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090,Mus musculus (house mouse),Protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mrna],,,PMID:33497687,https://www.ncbi.nlm.nih.gov/pubmed/33497687,33497687,,
385,1470321,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GPX1 mRNA,,,PMID:30934151|PMID:33242462|PMID:33497687,https://www.ncbi.nlm.nih.gov/pubmed/30934151|https://www.ncbi.nlm.nih.gov/pubmed/33242462|https://www.ncbi.nlm.nih.gov/pubmed/33497687,30934151|33242462|33497687,,
386,1470322,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of GPX1 mRNA,,,PMID:14691202|PMID:17451858|PMID:21396911,https://www.ncbi.nlm.nih.gov/pubmed/14691202|https://www.ncbi.nlm.nih.gov/pubmed/17451858|https://www.ncbi.nlm.nih.gov/pubmed/21396911,14691202|17451858|21396911,,
387,1470323,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of GPX1 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
388,1470324,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mrna],,,PMID:29935397,https://www.ncbi.nlm.nih.gov/pubmed/29935397,29935397,,
389,1470325,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased activity of GPX1 protein,,,PMID:37120063,https://www.ncbi.nlm.nih.gov/pubmed/37120063,37120063,,
390,1470499,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of GPX1 mRNA,,,PMID:29935397|PMID:37120063,https://www.ncbi.nlm.nih.gov/pubmed/29935397|https://www.ncbi.nlm.nih.gov/pubmed/37120063,29935397|37120063,,
391,1470500,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Sodium selenite inhibits the reaction [sodium arsenite results in increased expression of GPX1 mrna]|sodium arsenite results in increased expression of GPX1 mRNA,,,PMID:23603382,https://www.ncbi.nlm.nih.gov/pubmed/23603382,23603382,,
392,1470657,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6327,SCN2B,https://ctdbase.org/detail.go?type=gene&acc=6327,,,6327.0,SCN2B,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SCN2B mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
393,1470658,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6328,SCN3A,https://ctdbase.org/detail.go?type=gene&acc=6328,,,6328.0,SCN3A,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SCN3A mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
394,1470659,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55800,SCN3B,https://ctdbase.org/detail.go?type=gene&acc=55800,,,55800.0,SCN3B,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of SCN3B mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
395,1470660,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6329,SCN4A,https://ctdbase.org/detail.go?type=gene&acc=6329,,,6329.0,SCN4A,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of SCN4A mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
396,1470661,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6330,SCN4B,https://ctdbase.org/detail.go?type=gene&acc=6330,,,6330.0,SCN4B,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SCN4B mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
397,1470662,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6331,SCN5A,https://ctdbase.org/detail.go?type=gene&acc=6331,,,6331.0,SCN5A,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of SCN5A mRNA,,,PMID:21776218,https://www.ncbi.nlm.nih.gov/pubmed/21776218,21776218,,
398,1470663,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6334,SCN8A,https://ctdbase.org/detail.go?type=gene&acc=6334,,,6334.0,SCN8A,9606,Homo sapiens (human),Sodium arsenite affects the methylation of SCN8A gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
399,1470664,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6334,SCN8A,https://ctdbase.org/detail.go?type=gene&acc=6334,,,6334.0,SCN8A,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SCN8A mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
400,1470985,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407024,MIR29B1,https://ctdbase.org/detail.go?type=gene&acc=407024,,,407024.0,MIR29B1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of MIR29B1 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
401,1470986,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407025,MIR29B2,https://ctdbase.org/detail.go?type=gene&acc=407025,,,407025.0,MIR29B2,9606,Homo sapiens (human),Sodium arsenite affects the expression of MIR29B2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
402,1470987,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407025,MIR29B2,https://ctdbase.org/detail.go?type=gene&acc=407025,,,407025.0,MIR29B2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MIR29B2 mRNA,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
403,1470988,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407027,MIR301A,https://ctdbase.org/detail.go?type=gene&acc=407027,,,407027.0,MIR301A,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR301A mRNA,,,PMID:28972549,https://www.ncbi.nlm.nih.gov/pubmed/28972549,28972549,,
404,1470989,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407027,MIR301A,https://ctdbase.org/detail.go?type=gene&acc=407027,,,407027.0,MIR301A,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of MIR301A mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
405,1470990,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100126318,MIR301B,https://ctdbase.org/detail.go?type=gene&acc=100126318,,,100126318.0,MIR301B,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MIR301B mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
406,1471607,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422992,MIR3151,https://ctdbase.org/detail.go?type=gene&acc=100422992,,,100422992.0,MIR3151,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR3151 mRNA,,,PMID:29207610,https://www.ncbi.nlm.nih.gov/pubmed/29207610,29207610,,
407,1471608,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422989,MIR3155A,https://ctdbase.org/detail.go?type=gene&acc=100422989,,,100422989.0,MIR3155A,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MIR3155A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
408,1471609,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422988,MIR3156-1,https://ctdbase.org/detail.go?type=gene&acc=100422988,,,100422988.0,MIR3156-1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR3156-1 mRNA,,,PMID:28972549,https://www.ncbi.nlm.nih.gov/pubmed/28972549,28972549,,
409,1471610,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422900,MIR3158-1,https://ctdbase.org/detail.go?type=gene&acc=100422900,,,100422900.0,MIR3158-1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MIR3158-1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
410,1471611,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100423033,MIR3158-2,https://ctdbase.org/detail.go?type=gene&acc=100423033,,,100423033.0,MIR3158-2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MIR3158-2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
411,1471746,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,135154,SDHAF4,https://ctdbase.org/detail.go?type=gene&acc=135154,,,135154.0,SDHAF4,10090,Mus musculus (house mouse),Sodium arsenite results in decreased methylation of SDHAF4 gene|sodium arsenite results in increased methylation of SDHAF4 gene,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
412,1471747,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6390,SDHB,https://ctdbase.org/detail.go?type=gene&acc=6390,,,6390.0,SDHB,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SDHB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
413,1471748,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6390,SDHB,https://ctdbase.org/detail.go?type=gene&acc=6390,,,6390.0,SDHB,9606,Homo sapiens (human),Sodium arsenite results in increased expression of SDHB protein,,,PMID:27908234,https://www.ncbi.nlm.nih.gov/pubmed/27908234,27908234,,
414,1471749,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6390,SDHB,https://ctdbase.org/detail.go?type=gene&acc=6390,,,6390.0,SDHB,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of SDHB mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
415,1471750,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6391,SDHC,https://ctdbase.org/detail.go?type=gene&acc=6391,,,6391.0,SDHC,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SDHC mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
416,1471751,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,558391,SDK1A,https://ctdbase.org/detail.go?type=gene&acc=558391,,,558391.0,sdk1a,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SDK1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
417,1471752,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54549,SDK2,https://ctdbase.org/detail.go?type=gene&acc=54549,,,54549.0,SDK2,9606,Homo sapiens (human),Sodium arsenite affects the methylation of SDK2 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
418,1471753,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,561852,SDK2A,https://ctdbase.org/detail.go?type=gene&acc=561852,,,561852.0,sdk2a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SDK2A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
419,1471754,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,195814,SDR16C5,https://ctdbase.org/detail.go?type=gene&acc=195814,,,195814.0,SDR16C5,9606,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of SDR16C5 mRNA,,,PMID:32076005,https://www.ncbi.nlm.nih.gov/pubmed/32076005,32076005,,
420,1471755,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,195814,SDR16C5,https://ctdbase.org/detail.go?type=gene&acc=195814,,,195814.0,SDR16C5,9606,Homo sapiens (human),Sodium arsenite results in increased expression of SDR16C5 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
421,1471896,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100422875,MIR3192,https://ctdbase.org/detail.go?type=gene&acc=100422875,,,100422875.0,MIR3192,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR3192 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
422,1472177,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3996,LLGL1,https://ctdbase.org/detail.go?type=gene&acc=3996,,,3996.0,LLGL1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of LLGL1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
423,1472178,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3993,LLGL2,https://ctdbase.org/detail.go?type=gene&acc=3993,,,3993.0,LLGL2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of LLGL2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
424,1472179,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3998,LMAN1,https://ctdbase.org/detail.go?type=gene&acc=3998,,,3998.0,LMAN1,9606,Homo sapiens (human),Sodium arsenite affects the expression of LMAN1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
425,1472180,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3998,LMAN1,https://ctdbase.org/detail.go?type=gene&acc=3998,,,3998.0,LMAN1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of LMAN1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
426,1472181,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10960,LMAN2,https://ctdbase.org/detail.go?type=gene&acc=10960,,,10960.0,LMAN2,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of LMAN2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
427,1472684,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,407042,MIR34C,https://ctdbase.org/detail.go?type=gene&acc=407042,,,407042.0,MIR34C,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of MIR34C mRNA,,,PMID:25625412,https://www.ncbi.nlm.nih.gov/pubmed/25625412,25625412,,
428,1472685,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,494323,MIR361,https://ctdbase.org/detail.go?type=gene&acc=494323,,,494323.0,MIR361,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR361 mRNA,,,PMID:28972549,https://www.ncbi.nlm.nih.gov/pubmed/28972549,28972549,,
429,1472686,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100500827,MIR3614,https://ctdbase.org/detail.go?type=gene&acc=100500827,,,100500827.0,MIR3614,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MIR3614 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
430,1472687,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100500847,MIR3615,https://ctdbase.org/detail.go?type=gene&acc=100500847,,,100500847.0,MIR3615,9606,Homo sapiens (human),Sodium arsenite results in increased expression of MIR3615 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
431,1472688,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,574030,MIR362,https://ctdbase.org/detail.go?type=gene&acc=574030,,,574030.0,MIR362,9606,Homo sapiens (human),Sodium arsenite affects the expression of MIR362 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
432,1472689,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,574030,MIR362,https://ctdbase.org/detail.go?type=gene&acc=574030,,,574030.0,MIR362,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MIR362 mRNA,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
433,1472690,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100500918,MIR3651,https://ctdbase.org/detail.go?type=gene&acc=100500918,,,100500918.0,MIR3651,9606,Homo sapiens (human),Sodium arsenite affects the expression of MIR3651 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
434,1472860,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4001,LMNB1,https://ctdbase.org/detail.go?type=gene&acc=4001,,,4001.0,LMNB1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of LMNB1 protein,,,PMID:28229933,https://www.ncbi.nlm.nih.gov/pubmed/28229933,28229933,,
435,1472861,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84823,LMNB2,https://ctdbase.org/detail.go?type=gene&acc=84823,,,84823.0,LMNB2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of LMNB2 mRNA,,,PMID:12377979,https://www.ncbi.nlm.nih.gov/pubmed/12377979,12377979,,
436,1472369,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TP53 mRNA,,,PMID:19606018,https://www.ncbi.nlm.nih.gov/pubmed/19606018,19606018,,
437,1472370,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TP53 protein|trichostatin A results in decreased expression of TP53 protein mutant form,,,PMID:15179185,https://www.ncbi.nlm.nih.gov/pubmed/15179185,15179185,,
438,1472852,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7163,TPD52,https://ctdbase.org/detail.go?type=gene&acc=7163,,,7163.0,TPD52,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TPD52 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
439,1472853,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7163,TPD52,https://ctdbase.org/detail.go?type=gene&acc=7163,,,7163.0,TPD52,8355,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of TPD52 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
440,1472854,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7164,TPD52L1,https://ctdbase.org/detail.go?type=gene&acc=7164,,,7164.0,TPD52L1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TPD52L1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
441,1472855,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7164,TPD52L1,https://ctdbase.org/detail.go?type=gene&acc=7164,,,7164.0,TPD52L1,9606,Homo sapiens (human),Trichostatin A results in increased expression of TPD52L1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
442,1472856,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7167,TPI1,https://ctdbase.org/detail.go?type=gene&acc=7167,,,7167.0,TPI1,8355,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of TPI1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
443,1472857,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,192309,TPI1A,https://ctdbase.org/detail.go?type=gene&acc=192309,,,192309.0,tpi1a,7955,Danio rerio (zebrafish),Trichostatin A results in increased expression of TPI1A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
444,1472858,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7168,TPM1,https://ctdbase.org/detail.go?type=gene&acc=7168,,,7168.0,TPM1,7955,Danio rerio (zebrafish),Trichostatin A results in decreased expression of TPM1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
445,1472859,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7168,TPM1,https://ctdbase.org/detail.go?type=gene&acc=7168,,,7168.0,TPM1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPM1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
446,1492207,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,255743,NPNT,https://ctdbase.org/detail.go?type=gene&acc=255743,,,255743.0,NPNT,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPNT mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
447,1472035,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),Resveratrol results in decreased expression of ABCC1,,,PMID:19828106|PMID:20350534,https://www.ncbi.nlm.nih.gov/pubmed/19828106|https://www.ncbi.nlm.nih.gov/pubmed/20350534,19828106|20350534,,
448,1472036,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),[resveratrol results in decreased expression of ABCC1] which results in increased uptake of doxorubicin,,,PMID:20350534,https://www.ncbi.nlm.nih.gov/pubmed/20350534,20350534,,
449,1472037,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),ABCC2 protein affects the export of resveratrol,,,PMID:15686436,https://www.ncbi.nlm.nih.gov/pubmed/15686436,15686436,,
450,1472038,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),Resveratrol inhibits the reaction [ABCC2 protein affects the export of ochratoxin A],,,PMID:15955639,https://www.ncbi.nlm.nih.gov/pubmed/15955639,15955639,,
451,1472039,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),Resveratrol inhibits the reaction [genistein promotes the reaction [RXRA protein binds to ABCC2 promoter]],,,PMID:21689630,https://www.ncbi.nlm.nih.gov/pubmed/21689630,21689630,,
452,1472040,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),Resveratrol inhibits the reaction [genistein results in increased expression of ABCC2 protein]|resveratrol inhibits the reaction [genistein results in increased expression of ABCC2 mrna],,,PMID:21689630|PMID:26394120,https://www.ncbi.nlm.nih.gov/pubmed/21689630|https://www.ncbi.nlm.nih.gov/pubmed/26394120,21689630|26394120,,
453,1472041,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),Resveratrol results in decreased expression of ABCC2 mrna|resveratrol results in decreased expression of ABCC2 protein,,,PMID:26394120,https://www.ncbi.nlm.nih.gov/pubmed/26394120,26394120,,
454,1472042,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116,Rattus norvegicus (Norway rat),[probenecid results in decreased activity of ABCC2 protein] which results in decreased secretion of resveratrol metabolite|[verlukast results in decreased activity of ABCC2 protein] which results in decreased secretion of resveratrol metabolite,,,PMID:20089784,https://www.ncbi.nlm.nih.gov/pubmed/20089784,20089784,,
455,1549207,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9245,GCNT3,https://ctdbase.org/detail.go?type=gene&acc=9245,,,9245.0,GCNT3,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of GCNT3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
456,1549208,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9615,GDA,https://ctdbase.org/detail.go?type=gene&acc=9615,,,9615.0,GDA,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of GDA mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
457,1549209,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,78997,GDAP1L1,https://ctdbase.org/detail.go?type=gene&acc=78997,,,78997.0,GDAP1L1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of GDAP1L1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
458,1549210,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,54834,GDAP2,https://ctdbase.org/detail.go?type=gene&acc=54834,,,54834.0,GDAP2,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of GDAP2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
459,1549211,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2657,GDF1,https://ctdbase.org/detail.go?type=gene&acc=2657,,,2657.0,GDF1,9606,Homo sapiens (human),Resveratrol results in decreased expression of GDF1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
460,1607355,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,51200,CPA4,https://ctdbase.org/detail.go?type=gene&acc=51200,,,51200.0,CPA4,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of CPA4 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
461,1607356,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,93979,CPA5,https://ctdbase.org/detail.go?type=gene&acc=93979,,,93979.0,CPA5,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of CPA5 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
462,1607357,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1360,CPB1,https://ctdbase.org/detail.go?type=gene&acc=1360,,,1360.0,CPB1,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of CPB1 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
463,1607358,3000322,Comparative Toxicogenomics Database (CTD),Scopolamine,D012601,Scopolamine,https://ctdbase.org/detail.go?type=chem&acc=D012601,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),Serotonin analog inhibits the reaction [scopolamine results in decreased expression of BDNF protein]|tacrine inhibits the reaction [scopolamine results in decreased expression of BDNF protein],,,PMID:26408985,https://www.ncbi.nlm.nih.gov/pubmed/26408985,26408985,,
464,2002087,18823261,BindingDB,LOR-NOR-30067bb9-6,496474,LOR-NOR-30067bb9-6,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496474,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),12400,,,,,
465,2002086,20924587,BindingDB,"1-{3-[Butyl(phenyl)amino]propyl}-3-[2-(2-methylpropyl)-1-oxo-1,2-dihydroisoquinolin-4-YL]urea",496438,MAT-POS-b5746674-102,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496438,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),82700,,,,,
466,2035796,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Sirolimus promotes the reaction [acetaldehyde results in decreased phosphorylation of EIF4EBP1 protein],,,PMID:16962100,https://www.ncbi.nlm.nih.gov/pubmed/16962100,16962100,,
467,2035797,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Sirolimus promotes the reaction [cisplatin results in decreased phosphorylation of EIF4EBP1 protein],,,PMID:18058806,https://www.ncbi.nlm.nih.gov/pubmed/18058806,18058806,,
468,2012694,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,5732,PTGER2,https://ctdbase.org/detail.go?type=gene&acc=5732,,,5732.0,PTGER2,10116,Rattus norvegicus (Norway rat),[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein,,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
469,2012695,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,5734,PTGER4,https://ctdbase.org/detail.go?type=gene&acc=5734,,,5734.0,PTGER4,10116,Rattus norvegicus (Norway rat),[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein,,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
470,2012696,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,9536,PTGES,https://ctdbase.org/detail.go?type=gene&acc=9536,,,9536.0,PTGES,10116,Rattus norvegicus (Norway rat),[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA,,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
471,2055139,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,84932,RAB2B,https://ctdbase.org/detail.go?type=gene&acc=84932,,,84932.0,RAB2B,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB2B protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
472,2055140,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,83871,RAB34,https://ctdbase.org/detail.go?type=gene&acc=83871,,,83871.0,RAB34,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RAB34 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
473,2055141,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5869,RAB5B,https://ctdbase.org/detail.go?type=gene&acc=5869,,,5869.0,RAB5B,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB5B protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
474,2055142,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,4218,RAB8A,https://ctdbase.org/detail.go?type=gene&acc=4218,,,4218.0,RAB8A,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB8A protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
475,2055143,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,55684,RABL6,https://ctdbase.org/detail.go?type=gene&acc=55684,,,55684.0,RABL6,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RABL6 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
476,2055144,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,10399,RACK1,https://ctdbase.org/detail.go?type=gene&acc=10399,,,10399.0,RACK1,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RACK1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
477,2055145,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5887,RAD23B,https://ctdbase.org/detail.go?type=gene&acc=5887,,,5887.0,RAD23B,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAD23B protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
478,2055146,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,8480,RAE1,https://ctdbase.org/detail.go?type=gene&acc=8480,,,8480.0,RAE1,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAE1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
479,2055147,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,22913,RALY,https://ctdbase.org/detail.go?type=gene&acc=22913,,,22913.0,RALY,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RALY protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
